Investigation of Antimicrobial Secondary Metabolites from Bacterial Isolates Associated with the Hawaiian Bobtail Squid (Euprymna scolopes) by Gromek, Samantha
University of Connecticut 
OpenCommons@UConn 
Doctoral Dissertations University of Connecticut Graduate School 
12-2-2019 
Investigation of Antimicrobial Secondary Metabolites from 
Bacterial Isolates Associated with the Hawaiian Bobtail Squid 
(Euprymna scolopes) 
Samantha Gromek 
University of Connecticut - Storrs, samantha.gromek@uconn.edu 
Follow this and additional works at: https://opencommons.uconn.edu/dissertations 
Recommended Citation 
Gromek, Samantha, "Investigation of Antimicrobial Secondary Metabolites from Bacterial Isolates 
Associated with the Hawaiian Bobtail Squid (Euprymna scolopes)" (2019). Doctoral Dissertations. 2395. 
https://opencommons.uconn.edu/dissertations/2395 
Investigation of antimicrobial secondary metabolites from bacterial 
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A beneficial host-microbe symbiosis that has been extensively studied is the association of 
the Hawaiian bobtail squid, Euprymna scolopes, with the bioluminescent bacterium Vibrio fischeri 
in the squid light organ. Our research used the Hawaiian bobtail squid as a model system to begin 
investigating the functional role of secondary metabolites associated with the accessory nidamental 
gland (ANG), a reproductive organ present in sexually mature female cephalopods, and jelly coat 
(JC) bacteria. Using this model organism, prior research supports that bacteria from the ANG are 
deposited into the egg JC. Subsequently, the JC bacteria produce compounds as a chemical defense 
mechanism during their physically unprotected embryonic period. A suite of analytical chemistry 
techniques (e.g. tandem mass spectrometry, direct analysis in real time mass spectrometry, liquid 
chromatography mass spectrometry, nuclear magnetic resonance) has been utilized to perform 
extensive chemical profiling of ANG and JC bacteria. In addition, ANG and JC bacterial extracts 
tested in biological assays demonstrate potent inhibition against various pathogens including 
Vibrio spp., Fusarium keratoplasticum, and Candida albicans. This research investigates chemical 
defense mechanisms utilized within these symbiotic systems, including the influence of the host 
environment on the production of chemical compounds by bacterial symbionts. We have shown 
that the ANG and JC bacteria produce antimicrobial compounds, providing some insight into the 
possible function of the ANG.  
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Chapter I: Introduction 
 
 
  
2 
Natural products 
Natural products continue to be an abundant source for structurally diverse compounds 
originating from a variety of organisms including terrestrial and marine (Cragg and Newman, 
2013). These compounds can be broadly classified into primary and secondary metabolites. 
Primary metabolites (e.g. amino acids, nucleic acids, sugars) are vital for maturity, proliferation, 
and reproduction of an organism. In contrast, secondary metabolites are considered not essential 
for the normal development of an organism (Stanforth, 2006). Secondary metabolites provide 
specialized survival benefits to the producing organism through a variety of mechanisms including 
but not limited to, self-defense against competing organisms, increased fitness to harsh 
environmental conditions, and inter-cellular communication (Demain and Fang, 2000).  
Because of their biological role in the producing organism, secondary metabolites often 
possess potent biological activity and the potential to be utilized for preclinical drug candidates 
(Demain and Fang, 2000). Of the small molecule approved drugs from 1981 to 2014, 
approximately 38% are derived from natural products, semi-synthetic natural product analogues, 
or synthetic compounds based on natural product pharmacophores (Newman and Cragg, 2016). A 
majority of known natural products have emanated from studies of terrestrial organisms, primarily 
due to the ease of collecting large volumes of samples. (Adnani et al., 2017; Gerwick and Moore, 
2012). However, since the development of the self-contained underwater breathing apparatus 
(SCUBA) and remotely operated vehicles (ROV) technologies, researchers have been able to 
explore portions of the marine environment that were previously inaccessible. This had led to 
increased discovery of novel marine microorganisms that are capable of biosynthesizing diverse 
natural products (Gerwick and Moore, 2012). 
 
3 
Marine Natural Products 
Due to the abundance of marine environments around the world, there is a large amount of 
biodiversity that has not been fully exploited for drug discovery (Adnani et al., 2017; Donia and 
Hamann, 2013). This niche represents a reservoir from which scientists can continue to expand the 
chemical space through discovering and characterizing potent biologically active natural products 
(Adnani et al., 2017). Marine organisms have evolved to survive under various environmental 
stresses such as high salinity, low light, and increased pressure (Lindequist, 2016). Some of these 
organisms are relatively sessile and soft-bodied (e.g. tunicates, sponges) and therefore they are 
more vulnerable to predation and biofilm formation (Lindequist, 2016). To our benefit, intense 
competition and unique stressors have provided evolutionary pressure for many of these marine 
organisms to protect themselves through the production of defensive or functional secondary 
metabolites. 
One of the earliest marine metabolites was described from a marine sponge Tethya crypta 
collected near the Florida coast (Bergmann and Feeney, 1951; Bergmann and Burke, 1956). This 
class of compounds includes the unique nucleosides (spongothymidine and spongouridine) that 
are composed of arabinose residues instead of deoxyribose or ribose units (Figure 1) (Bergmann 
and Feeney, 1951; Bergmann and Burke, 1956). This discovery inspired the synthesis of two 
derivatives cytarabine (Cytosar-U; Ara-C) and vidarabine (Vira-A; Ara-A) that were later 
approved by the U.S. Food and Drug Administration (FDA) for the treatment of viral infections 
and cancer, respectively (Figure 1) (Stonik, 2009). 
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Figure 1. Arabino-nucleosides spongothymidine and spongouridine isolated from the marine 
sponge Tethya crypta and their synthetic derivatives cytarabine and vidrabine.  
 
After the arabino-nucelosides, ziconotide received FDA approval in 2004 for the treatment of 
severe chronic pain (Figure 2). Ziconotide is a synthetic form of ω-MVIIA, a peptide with 25 
amino acids and three disulfide bridges, originally isolated from the venom of Conus magus (cone 
snail) and identified to be a selective and potent inhibitor of N-type voltage gated calcium channels 
with minimal affinity to other calcium channel subtypes (McIntosh et al., 1982).  
 
 
Figure 2. Amino acid sequence and disulfide bridging pattern of ziconotide.  
 
In addition to the three aforementioned compounds, there have been two additional FDA 
approved drugs incorporating marine derived compounds, eribulin mesylate (Halaven) and 
5 
brentuximab vedotin (Adcetris). Eribulin mesylate is a synthetic analogue of halichondrin B that 
was originally isolated from a marine sponge Lissodendoryx sp. (Bai et al., 1991), and brentuximab 
vedotin is an antibody drug conjugate that integrates monomethyl auristatin E, a synthetic analogue 
of dolstatin 10. Dolstatin 10 was originally isolated from the marine mollusc Dolabella auricularia 
(Pettit et al., 1987; Luesch et al., 2001).  Furthermore, the European Medicines Evaluation Agency 
approved drug trabectedin was originally isolated from an ascidian Ecteinascidia turbinata and 
shown to have strong anticancer activity (Figure 3) (Lichter et al., 1972; Ruiz-Torres et al., 2017). 
These examples demonstrate the potential for marine organisms to produce structurally diverse 
and biologically active metabolites.  
 
 
Figure 3. Marine invertebrate U.S. Food and Drug Administration (FDA) and European 
Medicines Evaluation Agency (EMEA) approved drugs. 
6 
Symbiosis 
Symbiotic relationships can be defined as close interactions between two or more 
organisms (Adnani et al., 2017; Cleary et al., 2017; Lopanik et al., 2014). These relationships are 
commonly established between eukaryotic hosts and microorganisms (Moya et al., 2009). 
Symbioses are broadly categorized as mutualistic (both organisms benefit), commensalistic (one 
organism benefits and the other organism remains unharmed), or parasitic (one organism benefits 
and the other is harmed) (Dimijian, 2000). These relationships may be obligatory, meaning the 
organisms depend on each other for survival, or facultative where each organism can live 
independently (Adnani et al., 2017). Host-microbe symbioses have primarily been studied to 
advance basic science by understanding unique and complex ecological systems (Flórez et al., 
2015). However, bacterial symbionts associated with host organisms are emerging as promising 
sources for novel drug discovery because of the potential for bacterial symbionts to produce 
defensive secondary metabolites (Flórez et al., 2015).  
 
Invertebrate Microbial Symbioses  
Terrestrial: Defensive symbioses have been investigated in terrestrial and marine host-
microbe relationships where the bacterial symbiont produces secondary metabolites to either 
inhibit harmful pathogens or ward off predators (Kaltenpoth et al., 2014). Symbiotic bacteria 
associated with terrestrial invertebrates are known to protect the host’s nutritional resources by 
producing antimicrobial compounds (Kaltenpoth et al., 2014). For example, fungus-growing ants 
in the Attini tribe maintain a symbiotic relationship with a cultivar fungus, Leucoagaricus 
gongylophorus (Cafaro et al., 2011; Zhang et al., 2007). In this relationship, the ants provide 
nutrients to the cultivar fungus which serves as their primary nutritional source (Klassen, 2014). 
7 
The cultivar fungus is susceptible to numerous pathogens including the parasitic fungus 
Escovopsis. Therefore, various defense mechanisms have been adapted (Klassen, 2014; Currie et 
al., 1999). The most well-known defense mechanism in this system is the production of secondary 
metabolites by Pseudonocardia on the propleural plate of the ants to protect the cultivar fungus 
(Cafaro et al., 2011). Pseudonocardia has been shown to produce antimicrobial compounds such 
as dentigerumycin, a cyclic peptide, to protect the cultivar fungus against Escovopsis (Oh et al., 
2009). 
In addition to the protection of nutritional resources, research has focused on the protection 
of the terrestrial host from harmful microorganisms (Kaltenpoth et al., 2014). For example, female 
beewolf digger wasps, Philanthus spp., have antennal glands that associate with an 
actinobacterium Streptomyces philanthi (Kaltenpoth et al. 2014; Koehler et al., 2013; Kroiss et al.; 
2010). This bacterial symbiont is applied to the brood cell ceiling and then integrated into the 
cocoon subsequently producing antimicrobial compounds as a defense mechanism to protect the 
larvae from pathogenic microorganisms (Koehler et al., 2013; Kroiss et al.; 2010). Further 
investigation of S. philanthi determined the antimicrobial protection is primarily attributed to the 
production of piericidin analogues and streptochlorin (Figure 4) (Kroiss et al., 2010). These 
compounds are produced within the first two weeks of larval development, localized to the surface 
of the cocoon, and are stable for extended periods of time most likely due to the dark and dry 
climate within the cocoon surface limiting the exposure of the compounds to air, heat, light and 
moisture (Koehler et al., 2013). The long-term stability of the antibiotics is important for the 
protection of the beewolf during hibernation (Koehler et al., 2013) and may make for improved 
pharmacokinetic properties as these are explored for drug discovery and development. 
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Figure 4. Secondary metabolites produced by Streptomyces philanthi to protect the 
Philanthus spp. larvae. 
  
Marine:  Marine organisms are known to be prolific producers of secondary metabolites 
with potent biological activity (Newman and Cragg, 2004). In the ocean, marine invertebrates 
often establish symbiotic relationships with microbes due to their constant interaction of 
microorganisms from the seawater by filter feeding (Apprill, 2017; Lopanik, 2014). Sessile marine 
invertebrate organisms (e.g., mollusks, sponges, tunicates) and their associated microbial 
symbionts are a prime source for defensive secondary metabolites because these organisms lack 
or have limited mobility and therefore may rely upon structurally diverse and biologically active 
compounds to defend themselves (Schmidt et al. 2012; Schmidt et al., 2008).  
Numerous biologically active natural products have been isolated from sessile marine 
invertebrate organisms, although the true producers of these biologically active secondary 
metabolites are likely symbiotic microorganisms associated with these marine invertebrates 
(Morita and Schmidt, 2018; Kobayashi and Ishibashi, 1993). One example is dolstatin 10 that was 
originally isolated from the mollusc Dolabella auricularia (Figure 5) (Pettit et al., 1987). Dolstatin 
9 
10 is a modified linear peptide composed of five amino acid-like residues and was found to possess 
potent antitumor activity against NCI human melanoma, B16 melanoma, and PS leukemia in 
xenograph mouse models (Luesch et al., 2001), Dolstatin 10 was found to be produced by a species 
of the marine cyanobacterium, Symploca sp., that is consumed by the mollusc D. auricularia 
(Luesch et al., 2002). Another example is dysidenin, a highly chlorinated peptide derivative, 
initially isolated from the sponge Dysidea herbacea (Figure 5) (Kazlauskas et al., 1977), but 
further investigation using cell separation, fluorescence in situ hybridization, and genetic probes 
identified Oscillatoria spongeliae, cyanobacterial symbiont, as the producer of these compounds 
(Flatt et al., 2005).  
There is also a symbiotic relationship between the bryozoan Bulga neritina and the 
gammaproteobacterial symbiont Candidatus Endobugula seratula (Haygood and Davidson, 
1997). The bryostatins are macrocyclic polyketides that were originally isolated from B. neritina 
(Figure 5) (Pettit et al., 1982). These compounds are protein kinase C modulators and found to 
deter fish from preying on larvae (Lopanik et al., 2004). Because the bryostatins were structurally 
similar to bacterial secondary metabolites, the origin of these compounds was hypothesized to 
come from E. seratula. After discovering a bryostatin biosynthetic gene cluster in E. seratula the 
bacterium was determined to be the most likely the source of the bryostatins (Hildebrand et al. 
2004, Sudek et al., 2007).   
10 
 
Figure 5. Select examples of secondary metabolites associated with sessile marine 
invertebrates.  
 
In mobile marine invertebrate organisms (e.g., shrimp, squid) microbial symbionts may 
also produce secondary metabolites for defense, but have typically been related to protection of 
eggs or larval stages. One of the earliest examples of symbiont mediated chemical defense was 
highlighted in crustaceans. In Palaemon macrodactylus (caridean shrimp) an epibiotic Altermonas 
sp. bacterium was consistently isolated from the surface of larvae and subsequently shown to 
produce 2,3-indolinedione (isatin) (Figure 6) (Gil-Turnes et al., 1989). After the larvae were 
treated with antibiotics to eliminate bacterial symbionts, they were reinoculated with 
either Altermonas sp. culture or isatin. The results suggested both the Altermonas sp. culture and 
isatin improved embryo survival and reduced colonization of Lagenidium callinectes, a marine 
11 
fungal pathogen frequently associated with crustaceans (Gil-Turnes et al., 1989). A similar study 
isolated an unidentified Gram-negative bacterium from the embryos of Homarus americanus 
(American lobster) that was found to produce 4-hydroxyphenethyl alcohol (tyrosol) (Figure 6). 
This compound also demonstrated inhibition of L. callinectes (Gil-Turnes and Fenical, 1992). A 
similar chemical defense mechanism is hypothesized to occur with marine organisms that deposit 
egg clutches. 
 
 
Figure 6. Antifungal secondary metabolites produced by bacterial symbionts associated with 
crustaceans. 
 
Cephalopods such as the Hawaiian bobtail squid are known to deposit egg clutches on 
benthic substrates in the ocean (Kerwin and Nyholm, 2018; Lee et al., 2009). The eggs and larvae 
of marine organisms are exposed to numerous microorganisms in the ocean (Goeke et al., 2010). 
In this competitive environment, cephalopod egg clutches should be vulnerable to fouling and 
biofilm formation due to lack of parental care. Despite this, these eggs are resistant to fouling and 
biofilm formation during their embryonic development period which can range from several weeks 
to months (Benkendorff et al., 2001; Montgomery and McFall-Ngai, 1993; Fields, 1965). 
Therefore, these eggs must rely on mechanisms for protection to ensure successful development 
(Fields, 1965).  
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Hawaiian bobtail squid  
One of the most well-studied marine host-microbe relationships is the binary symbiosis of 
the Hawaiian bobtail squid, Euprymna scolopes, with the bioluminescent bacterium Vibrio fischeri 
in the squid light organ (Nyholm and McFall-Ngai, 2004; McFall-Ngai, 2002; McFall-Ngai and 
Ruby, 1991). In this symbiosis, V. fischeri protect the nocturnal host from predation using 
counterillumination to mimic the moonlight conditions while the squid forage for food (Jones and 
Nishiguchi, 2004). After V. fischeri colonize in the light organ the ciliated appendages around the 
light organ undergo apoptosis initiated by lipopolysaccharide and peptidoglycan (Nyholm and 
McFall-Ngai, 2004). Throughout the day the bacterial concentration of V. fischeri increases within 
the light organ (Nyholm and McFall-Ngai, 2004). At night the increased cell population induces 
the transcription of luciferase causing the luminescence (Lupp and Ruby, 2005). In the morning, 
the squid vents approximately 95% of V. fischeri into the surrounding seawater to maintain a stable 
population for juveniles (Nyholm and McFall-Ngai, 1998). The Hawaiian bobtail squid is a 
tractable experimental model to study the chemical defense mechanisms utilized within this 
symbiotic system because there is a single bacterial symbiont associated with the host, both 
partners can be cultured independently, and V. fischeri can be genetically manipulated to study the 
colonization of this bacteria within the light organ (McFall-Ngai, 2014). 
 In addition to the light organ, these organisms have an accessory nidamental gland (ANG) 
(Figure 7A-B) (Collins et al., 2015; Collins et al., 2012). The ANG is a reproductive organ present 
in many sexually mature female species of squid and cuttlefish (Kerwin and Nyholm, 2018; 
Kerwin and Nyholm, 2017; Collins et al., 2015; Collins et al., 2012). Within the ANG are 
pigmented epithelium lined tubules with a microvilli brush border (Figure 7C) (Collins et al., 2015; 
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Collins et al., 2012; Bloodgood, 1977). These tubules are composed of dense bacterial populations 
that each contain a distinct bacterial taxon (Figure 7D) (Collins et al., 2015; Collins et al., 2012).  
 
 
Figure 7. Relationship of the nidamental gland (NG), accessory nidamental gland (ANG), 
light organ (LO), and jelly coat (JC) with squid eggs. (A) This image is a ventral dissection of 
the Hawaiian bobtail squid representing the position of the NG, ANG, and LO that harbors the 
bioluminescent bacterium V. fischeri (Collins et al., 2012). (B) An enlarged diagram of the NG 
and ANG. (C) The epithelium lined tubules composed of dense bacterial communities within the 
ANG. (D) Pigmented bacterial isolated from the ANG. Transmission electron microscopy image 
of the cross section of the jelly coat and egg clutch image courtesy of Drs. Allison Kerwin and 
Spencer Nyholm.  
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The bacterial community of E. scolopes ANG was found to be dominated by 
Alphaproteobacteria that is similar to the ANG bacterial communities associated with other 
cephalopod species (Collins et al., 2012; Pichon et al., 2005; Grigioni et al., 2000). Further 
investigation determined a majority of the ANG bacteria are from the Roseobacter clade within 
Alphaproteobacteria (Collins et al., 2015; Collins et al., 2012). More specifically, Leisingera 
(previously classified as Phaeobacter) has been identified as the dominant genus in the ANG 
(Collins et al., 2015; Collins et al., 2012). In addition to Alphaproteobacteria, the ANG of E. 
scolopes was comprised of Rhizobiales, Verrucomicrobia, and Flavobacteria (Collins et al., 2015; 
Collins et al., 2012). Interestingly, the ANG bacterial community in E. scolopes is different from 
other cephalopods due to the presence of Verrucomicrobia and lack of Gammaproetobacteria 
(Kerwin and Nyholm, 2018; Kerwin and Nyholm, 2017; Collins et al., 2012). 
Although Proteobacteria are underexplored for secondary metabolites (Machado et al., 
2015), some species from the Roseobacter clade are known to produce antimicrobial compounds 
such as tropodithetic acid, roseobacticides, and indigoidine (Figure 8) (Seyedsayamdost et al., 
2011; Cude et al., 2012; Geng et al; 2008; Bruhn et al. 2005). Tropodithetic acid is known to inhibit 
the growth of Vibrio anguillarum on fish larvae (Geng et al; 2008; Bruhn et al., 2005). 
Roseobacticides demonstrate potent selective algaecidal activity against Emiliania huxleyi and 
Rhodomonas salina (Seyedsayamdost et al., 2011). Indigoidine has been shown to reduce 
colonization of V. fischeri (Cude et al., 2012).  
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Figure 8. Antimicrobial secondary metabolites produced by bacteria within the Roseobacter 
clade.  
  
The ANG is located in close proximity to the nidamental gland and posterior to the light 
organ that contains the bioluminescent bacterium V. fischeri (Figure 7B) (Collins et al., 2012; 
Kaufman et al., 1998; Bloodgood, 1977). While previous research has established that the 
nidamental gland (NG) of E. scolopes is responsible for producing the jelly coat (JC) that surrounds 
squid eggs (Atkinson, 1973), the function of the ANG and associated bacteria remains elusive. 
One proposed hypothesis is that the bacteria from the ANG are added into the JC (Kaufman et al., 
1998; Collins et al., 2012) and produce antimicrobial compounds to defend the eggs from fouling 
and predators during their physically unprotected embryonic period (Biggs and Epel, 1991).  
 Additional studies have investigated the ANG for antimicrobial properties. One of the 
earliest studies tested butanol extracts of the ANG and jelly coat from L. pealei against several 
bacterial and fungal pathogens (Barbieri et al., 1997). The ANG extract demonstrated antibacterial 
activity against Vibrio anguillarum, Aeromonas salmonicida, and Streptomyces griseus (Barbieri 
et al., 1997). However, the jelly coat extract did not inhibit any pathogens (Barbieri et al., 1997). 
In another study, butanol extracts were prepared from the ANG of L. duvuceli at three different 
maturity stages (immature, ripe, and spent) and tested for antibacterial activity (Gomathi et al., 
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2010). After evaluating the three extracts, only the ripe ANG extract was able to inhibit E. coli, P. 
aeruginosa, and S. aureus (Gomathi et al., 2010). Further analyses revealed the ripe extract 
consisted of increased concentrations of unsaturated fatty acids that may contribute to the 
biological activity (Gomathi et al., 2010). In a similar study, organic extracts from the ANG of 
Sepioteuthis lessoniana at four different maturity stages (immature, maturing, ripe, and spent) were 
tested for antibacterial activity (Venkatesan et al., 2014). The ripe ANG extracts exhibited the 
strongest activity against E. coli, A. hydrophila, S. aureus, and B. megaterium, while the immature 
ANG extracts had no antibacterial activity (Venkatesan et al., 2014). Although these studies 
suggest the ANG has antimicrobial properties, there is lack of evidence that the defensive function 
is due to the production of secondary metabolites by bacterial symbionts.  
 
Research Objectives 
Currently, the function of the ANG in the Hawaiian bobtail squid and the associated 
bacteria remains elusive. While research has suggested that ANG-associated bacteria are deposited 
into the egg JC and can produce defensive secondary metabolites, there has not been experimental 
proof of this function or any isolation or identification of metabolites from the ANG or JC bacteria. 
The overall goal of this research project is to identify biologically active compounds associated 
with the ANG and utilize comparative metabolomics to investigate secondary metabolite profiles 
of bacteria isolated from the ANG and JC. In this research project, three separate experimental 
sections are included: (1) Leisingera sp. JC1, a bacterial isolate from the Hawaiian bobtail squid 
eggs, produces indigoidine and differentially inhibits vibrios, (2) bacteria associated with the 
Hawaiian bobtail squid protect eggs from fungal fouling, and (3) chemical networking analyses to 
identify secondary metabolites from Labrenzia sp. ANG18, a bacterial symbiont. 
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1. Leisingera sp. JC1, a bacterial isolate from the Hawaiian bobtail squid eggs, produces 
indigoidine and differentially inhibits vibrios 
In this chapter, a jelly coat bacterium, Leisingera sp. JC1, will be investigated for its ability 
to produce antimicrobial compounds due to similar pigmentation and colony morphology to  
Leisingera sp. Y4I, a strain known to biosynthesize the antibiotic, indigoidine. Mass spectrometry 
will be used to investigate the production of indigoidine by JC1 and the genome of Leisingera sp. 
JC1 will be analyzed for known biosynthetic gene clusters. Furthermore, the regulation of 
indigoidine will be investigated through co-culture experiments with marine pathogens to explore 
the role of indigoidine in this host-microbe system. 
 
2. Bacteria associated with the Hawaiian bobtail squid protect eggs from fungal fouling 
In this chapter, in vivo experiments with egg clutches will be performed to determine if the 
JC bacterial community protects the eggs from fungal fouling.  ANG and JC bacterial extracts will 
be evaluated for antifungal activity through in vitro biological assays against filamentous and yeast 
fungal pathogens. Lastly, comparative metabolomics will be used to identify defensive secondary 
metabolites that may be used to protect the eggs from fungal fouling.  
 
3. Chemical networking analyses reveals secondary metabolites from Labrenzia sp. ANG18, a 
bacterial symbiont 
In this chapter, Labrenzia sp. ANG18, an accessory nidamental gland bacterial isolate, will 
be tested for antifungal activity against three phylogenetically related Fusarium keratoplasticum 
strains and C. albicans. In addition, the Labrenzia sp. ANG18 genome will be analyzed via 
analysis of the genome with antibiotic and secondary metabolite shell (antiSMASH) (Weber et al., 
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2015) to identify known biosynthetic gene clusters.  Lastly, a suite of mass spectroscopic and 
nuclear magnetic resonance techniques will be used to isolate and identify biologically active 
constituents of Labrenzia sp. ANG18. 
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Chapter II: Leisingera sp. JC1, a Bacterial Isolate from Hawaiian Bobtail Squid Eggs, 
Produces Indigoidine and Differentially Inhibits Vibrios 
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Introduction 
Marine host-microbe assemblages are emerging as a promising source of lead compounds 
for drug discovery due to the production of biologically active compounds as a chemical defense 
mechanism (Simmons et al., 2008). Some bacterial symbionts associated with marine invertebrates 
(e.g. bryozoans, soft corals, tunicates, and molluscs) have been shown to produce compounds to 
protect the host from fouling and predators (Morita and Schmidt, 2018; Flórez et al., 2015). 
Because the host is constantly exposed to microorganisms, the host may select microbes and co-
evolve with these microbial symbionts to produce compounds that benefit the host (Lopanik, 
2014). However, there is still difficulty understanding the functional role of compounds within 
symbiotic relationships because of the complex interactions among the host, microbial symbionts, 
environmental pathogens, and/or predators (Morita and Schmidt, 2018).     
One well-studied marine host-microbe relationship is the interaction of the Hawaiian 
bobtail squid, Euprymna scolopes, with the bioluminescent bacterium Vibrio fischeri in the squid 
light organ (Nyholm and McFall-Ngai, 2004; McFall-Ngai, 2002; McFall-Ngai and Ruby, 1991). 
In addition to the light organ, these cephalopods have an accessory nidamental gland (ANG) found 
in sexually mature females (Collins et al., 2012). The ANG is composed of pigmented epithelium 
lined tubules that each contain distinct bacterial taxon (Collins et al., 2012). Numerous bacterial 
taxa are found within the ANG, however Alphaproteobacteria, Gammaproteobacteria, and 
Verrucomicrobia, are dominant (Kerwin and Nyholm, 2017; Collins et al., 2015; Collins et al., 
2012). The majority of ANG bacteria are from the Roseobacter clade of Alphaproteobacteria. 
There are several examples of species from the Roseobacter clade producing antimicrobial 
compounds, such as Phaeobacter species producing tropodithietic acid (TDA) (Berger et al., 2011; 
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Geng et al., 2008) and Leisingera sp. Y4I (formerly Phaeobacter) producing indigoidine (Cude et 
al., 2012).  
While previous research has determined that the nidamental gland (NG) of E. scolopes is 
responsible for producing the jelly coat (JC) that surrounds squid eggs, the function of the ANG 
and associated bacteria remains unproven (Collins et al., 2015; Collins et al., 2012; Bloodgood, 
1977). One proposed hypothesis is the ANG works in conjunction with the NG to secrete bacteria 
in the egg JC, and the bacteria produce biologically active secondary metabolites as a chemical 
defense mechanism to protect the physically unprotected eggs against pathogenic microorganisms 
and predators (Kerwin and Nyholm, 2017; Collins et al., 2012; Biggs and Epel, 1991). The 
potential for ANG bacteria to produce secondary metabolites was supported by genomic analysis 
revealing several biosynthetic gene clusters including polyketide/non-ribosomal peptide 
synthases, terpenes, and bacteriocins (Collins et al., 2015).  
In this chapter, a jelly coat bacterium isolated from squid eggs, Leisingera sp. JC1, was 
investigated for the production of antimicrobial compounds due to the similar pigmentation and 
colony morphology as Leisingera sp. Y4I strain known to biosynthesize the antibacterial 
compound, indigoidine. LC-MS was used to identify the production of indigoidine by Leisingera 
sp. JC1 and DART-MS was used to investigate the possible localization of indigoidine to the outer 
edges of the Leisingera sp. JC1 bacterial colonies in the presence of V. fischeri, the light organ 
bacterial symbiont. In addition, Leisingera sp. JC1 and bacterial extracts were evaluated using in 
vitro biological assays for the ability to inhibit marine vibrios. Lastly, the regulation of indigoidine 
biosynthesis was investigated via co-culture experiments with vibrio strains to evaluate whether 
indigoidine may be a defensive metabolite associated with the Hawaiian bobtail squid.  
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Results and Discussion 
Detection of Indigoidine Production by Leisingera sp. JC1 
In a previous study, Leisingera sp. Y4I strain was found to produce indigoidine, a 
secondary metabolite shown to reduce surface colonization and growth of V. fischeri (Cude et al., 
2012). Due to similar colony morphology and pigmentation as the Y4I strain, a bacterium isolated 
from the jelly coat (JC) of squid eggs, Leisingera sp. JC1, was investigated for indigoidine 
production. Leisingera sp. JC1 was cultured using a three-step process to promote secondary 
metabolite production during the late growth phase of the bacterium resulting in a deep blue liquid 
culture possibly indicative of indigoidine (Ruiz et al., 2010). Because indigoidine is known to be 
insoluble in most organic solvents (Novakova et al., 2010), a resin-based extraction protocol 
afforded minimal quantities of indigoidine integrating to 0.8% in the extract as determined via 
liquid chromatography mass spectrometry analysis (LC-MS) (Figure 9D and 9E). To more 
efficiently extract indigoidine from cultures, a centrifugation method (Yu et al., 2013) was 
employed to separate indigoidine from media and cellular components. After centrifugation, the 
indigoidine-enriched pellet was dissolved in dimethyl sulfoxide (DMSO) yielding an indigoidine 
enriched extract with greater quantities of indigoidine (91.1%).  (Figure 9D) (Yu et al., 2013).  
The indigoidine enriched extract was analyzed via LC-MS to confirm the production of 
indigoidine (Figure 9A-C) with [M-H]- of 247.0 eluting at 10.7 minutes, consistent with the 
molecular weight (248.2 g/mol), molecular formula C10H9N404, and fragmentation pattern from 
previous literature (Yu et al., 2013; Cude et al., 2012). Indigoidine was originally identified in 
Pseudomonas indigofera (Elazari-Volcani, 1939) and also detected in Streptomyces species 
(actinobacteria) and Alpha-, Beta-, and Gammaproteobacteria (Cude et al., 2012; Takahashi et al., 
200; Reverchon et al., 2002). Indigoidine is a bicyclic 3,3'-bipyridyl compound synthesized by a 
23 
non-ribosomal polyketide synthase through the condensation of two glutamine molecules (Cude 
et al., 2015; Cude et al. 2012). Furthermore, indigoidine can be reduced to a colorless form, 
leucoindigoidine (Cude et al., 2012; Heumann et al., 1968). Subsequent exposure of 
leucoindigoidine to atmospheric oxygen is hypothesized to spontaneously oxidize the reduced 
form to indigoidine (Cude et al., 2012; Heumann et al., 1968).   
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Figure 9. Chemical analysis of indigoidine production by Leisingera sp. JC1 and 
quantification of indigoidine in the normal and indigoidine enriched extract. (A) Structure of 
indigoidine. (B) Extracted ion chromatogram (EIC) of ([M-H]- 247) to confirm the production of 
indigoidine (248.19 g/mol) by Leisingera sp. JC1. (C) Negative ionization mass spectrum of the 
peak at 10.7 min. The [M-H]- peak of 247.0 is consistent with a molecular formula of C10H9N404, 
confirming the presence of indigoidine (248.19 g/mol) (Yu et al. 2013). (D) The normal extract 
(blue) and indigoidine enriched extract (red) were monitored via LC-MS at UV 299 nm using an 
isocratic method. The quantity of indigoidine, eluting at tR 8.2 mins, was measured in both extracts 
using the area under the curve resulting in greater amounts of indigoidine found in the indigoidine 
enriched extract (91.1%) and minimal amounts (0.8%) of indigoidine present in the normal extract. 
(E) Negative ionization mass spectrum of the normal extract at tR 8.2 minutes. Although there is 
an ion [M-H]- 247.2 in the normal extract, there are several additional ions in greater relative 
abundance and minimal traces of indigoidine observed in D.   
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Antibacterial Activity of Leisingera sp. JC1 
 Leisingera sp. JC1 was cultured in large scale and extracted using either the indigoidine- 
enriched or normal extraction method to determine if indigoidine was responsible for the 
antibacterial activity. Both extracts were initially tested at 500 µg/mL in a 96-well liquid assay 
against the squid light organ bacterial symbiont, V. fischeri ES114, and two common marine 
pathogens V. anguillarum 775 and V. parahaemolyticus KNH1 (Figure 10). The normal extract 
demonstrated potent inhibition against V. fischeri with a percent control activity (PCA) value of 
17.9 ± 9.3 whereas the indigoidine-enriched extract exhibited moderate inhibition against V. 
fischeri with a PCA value of 63.3 ±6.7. There was no inhibition observed by either extract against 
V. anguillarum or V. parahaemolyticus.  
Previous studies with Leisingera sp. Y4I suggest a direct correlation between the 
production of indigoidine and inhibition of V. fischeri, with hyperpigmented mutant strains of Y4I 
demonstrating stronger antimicrobial activity (Cude et al., 2012). Although the indigoidine-
enriched extract reduced the growth of V. fischeri, the normal extract had more potent activity with 
trace amounts of indigoidine present, potentially due to the presence of additional secondary 
metabolites. Whole genome sequencing of Leisingera sp. JC1 (Appendix Figure A1) and analysis 
using the antibiotics and Secondary Metabolite Analysis Shell (antiSMASH) (Weber et al., 2015) 
revealed several secondary metabolite biosynthetic gene clusters including indigoidine, 
siderophore, bacteriocin, and homoserine lactone clusters. These results indicate indigoidine may 
not be solely responsible for the biological activity. While some bacteria within the roseobacter 
clade are known to produce the antimicrobial compound TDA (Berger et al., 2011; Geng et al., 
2008), to date none of our ANG and JC genomes that have been sequenced possess the biosynthetic 
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genes for this compound (Gromek et al., 2016; Collins et al., 2015) and TDA has not been detected 
in any of the ANG and JC bacterial extracts analyzed via LC-MS (data not shown). 
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Figure 10. Leisingera sp. JC1 extracts demonstrate differential activity against marine 
vibrios in a 96-well liquid assay. The indigoidine (igi) enriched extract and normal extract were 
tested at 500 µg/mL against V. fischeri, V. anguillarum, and V. parahaemolyticus. The normal 
extract demonstrated potent inhibition against V. fischeri, PCA 17.9 ± 9.3, whereas the igi enriched 
extract exhibited moderate inhibition against V. fischeri, PCA 63.3 ±6.7. Neither extract inhibited 
V. anguillarum or V. parahaemolyticus. Percent control activity (PCA) determined in comparison 
to the negative control (DMSO). The positive control, chloramphenicol, was tested at 2.5 µg/mL. 
Data represented are average PCA values from three biological replicates.  
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 Leisingera sp. JC1 was also tested using a solid media assay against the three marine 
vibrios above as well as P. leiognathi KNH6 and V. harveyi B392 to determine the zones of 
inhibition (ZOI) (Figure 11). P. leiognathi, bioluminescent bacterium, was isolated from Hawaiian 
seawater, and V. harveyi is another common marine pathogen. In order to mimic the environmental 
bacterial concentrations four different densities were selected, 104-107 CFU/mL (Goecke et al., 
2010; Urakawa and Rivera, 2006). The results suggest that JC1 demonstrated differential activity 
against the five vibrio species with more potent inhibition against V. fischeri and V. anguillarum 
at all four densities (Figure 11A). There was significantly greater inhibition of V. fischeri at 104-
106 CFU/mL in comparison to 107 CFU/mL. The results also suggest that JC1 was more effective 
at inhibiting P. leiognathi at lower densities, 104 and 105 CFU/mL. In addition, JC1 did not exhibit 
inhibition of V. parahaemolyticus or V. harveyi.  
Results from the ZOI assays and the 96-well assays were in agreement for V. 
parahaemolyticus. However, for V. anguillarum, the results differed between the ZOI and 96-well 
assay. Both extracts showed no inhibition against V. anguillarum whereas Leisingera sp. JC1 was 
able to inhibit this vibrio strain in the ZOI assay. The difference in activity may be due to the 
exclusion of aqueous soluble compounds during the extraction process. Moreover, compounds 
may diffuse or interact differently in liquid versus solid media. Another proposed hypothesis is 
that indigoidine may be reduced to leucoindigoidine under biological conditions and the reduced 
state may be responsible for the antibacterial activity (Cude et al., 2012). Because leucoindigoidine 
is easily converted to indigoidine in nonreducing conditions, testing the reduced state is difficult 
in biological assays (Cude et al., 2012).  
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Figure 11. Leisingera sp. JC1 demonstrates strong inhibition against V. fischeri and V. 
anguillarum in zone of inhibition assays. (A) Leisingera sp. JC1 was tested against V. fischeri, 
P. leiognathi, V. anguillarum, V. parahaemolyticus, and V. harveyi. The zone of inhibition was 
determined around JC1 bacterial colonies using four different bacterial concentrations, 104 
CFU/mL, 105 CFU/mL, 106 CFU/mL, and 107 CFU/mL on solid media. JC1 inhibited V. fischeri 
and V. anguillarum at all four bacterial concentrations with significantly greater inhibition of V. 
fischeri at 104-106 CFU/mL. JC1 inhibited P. leiognathi at 104 and 105 CFU/mL. However, no 
inhibition was observed for P. leiognathi at the two higher bacterial concentrations, 106 and 107 
CFU/mL. In addition, JC1 did not inhibit V. parahaemolyticus or V. harveyi. Letters above the bar 
graphs indicate statistically significant differences between bacterial concentrations after data 
analysis using post hoc Tukey tests. The following are 24 h images for JC1 tested against (B) no 
vibrio species (C) V. fischeri (D) P. leiognathi (E) V. anguillarum (F) V. parahaemolyticus (G) V. 
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harveyi. The bacterial concentration was 106 CFU/mL for (C-G) and scale bars are 5 mm (B-G). 
[Dr. Andrea Suria generated data and figure.]  
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Localization of Indigoidine Production by Leisingera sp. JC1  
  While performing ZOI assays the vibrio strains induced a distinct phenotypic change to 
Leisingera sp. JC1. Leisingera sp. JC1 grown alone appeared to have uniform indigoidine 
production (Figure 11B). However, in the presence of vibrio strains, JC1 appeared to localize 
indigoidine production to the outer edges of the colony (Figure 11C-G). To investigate the 
production of indigoidine across the JC1 bacterial colony, direct analysis in real time-mass 
spectrometry (DART-MS) was selected. This mass spectrometry technique has been used to detect 
natural products from microorganisms with minimal sample preparation required (Bouslimani et 
al., 2014; Sanchez et al., 2011).  
The production of indigodine across Leisingera sp. JC1 colonies was monitored over 7 
days in the presence or absence of V. fischeri (Figure 12) and five locations were selected: center 
(A), midpoint (B), edge (C), ZOI (D), and outside ZOI (E). Locations A-C were selected because 
they were the areas of most interest due to pigmentation, and locations D-E were chosen to 
determine if indigoidine permeated into the agar. The results indicate a relatively uniform 
production of indigoidine across the JC1 colony in the absence of V. fischeri (Figure 12, locations 
A-C). However, in the presence of V. fischeri indigoidine was found to localize to the edge of the 
colony (Figure 12, location C) with minimal amounts of indigoidine present in the center and 
midpoint (Figure 12, locations A-B). In both the absence and presence of V. fischeri, only trace 
amounts of indigoidine were detected in the ZOI and outside the ZOI (Figure 12, locations D-E), 
indicating that indigoidine is not diffusing into the agar. 
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Figure 12. Utilization of DART-MS to monitor the localization of indigoidine production by 
Leisingera sp. JC1 in the presence of V. fischeri. Direct analysis in real time-mass spectrometry 
(DART-MS) was used to detect indigoidine production over 7 days by Leisingera sp. JC1 in the 
absence (top images) and presence (bottom images) of V. fischeri. Five locations (A-E) were 
selected across the colony. In the absence of V. fischeri, uniform production of indigoidine was 
identified across the colony (locations A-C) whereas in the presence of V. fischeri indigoidine 
localized towards the outer edges of the colony (location C). Minimal quantities of indigoidine 
were detected in the zone of inhibition (ZOI) and outside the ZOI in the presence and absence of 
V. fischeri (locations D-E). Heat map represents relative abundance of indigoidine production from 
less abundance (black) to more abundance (bright red).   
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The localization of indigoidine to the outer edges of JC1 colonies may be indicative of a 
chemical defense mechanism to protect from V. fischeri, by localizing production to areas of direct 
interaction with other microorganisms. Production of secondary metabolites for defense diverts 
energy from the host’s biological functions such as growth and reproduction and thus may only be 
advantageous at areas vulnerable to attack (Pawlik, 2012). Some sessile marine organisms such as 
sponges and sea cucumbers allocate biologically active compounds to locations that are more 
susceptible to harmful pathogens and predators (Furrow et al., 2003; Van Dyck et al., 2010). 
Previous studies have shown induced pigment production through competitive bacterial 
interactions (Hoshino et al., 2015; Carlson et al., 2015). For example, Staphylococcus aureus was 
co-cultured with Pseudomonas aeruginosa displaying intense golden pigmentation at the outer 
edges of the S. aureus colony (Antonic et al. 2013). This pigmentation was associated with 
increased production of staphyloxanthin, an antioxidant compound (Antonic et al. 2013). In 
another study, Tsukamurella pulmonis induced the production of actinorhodin and 
undecylprodigiosin, antibiotic red pigments, from Streptomyces lividans (Onaka et al., 2011).  
Similar to the aforementioned studies, Leisingera sp. JC1 exhibited increased localized 
production of indigoidine at the outer edges of the colony in the presence of V. fischeri, likely as 
a defense mechanism. Additional contributing factors that could be inducing indigoidine 
production including homoserine lactones (Cude et al., 2015). In the Leisingera sp. Y4I strain, N-
(3-oxododecanoyl)-L-homoserine lactone (3-Oxo-C12:1-HSL) and N-octanoyl-homoserine lactone 
(C8-HSL) were the dominant compounds produced at the exponential and stationary growth phase, 
respectively (Cude et al., 2015). These homoserine lactones are hypothesized to induce the 
production of indigoidine through initial synthesis of 3-Oxo-C12:1-HSL by the PhaI gene until 
stationary phase. Then, increased concentrations of 3-Oxo-C12:1-HSL induces the pgaI gene to 
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produce C8-HSL resulting in indigoidine production (Cude et al., 2015). Another possible factor 
could involve oxidation of leucoindigoidine to indigoidine at the edges of the JC1 colony by V. 
fischeri (Heumann et al. 1964).  
 
Regulation of Indigoidine Production by Leisingera sp. JC1 
After determining the localization of indigoidine to the outer edges of the JC1 colony in 
the presence of V. fischeri, liquid media co-culture experiments were performed with V. fischeri, 
V. anguillarum, and V. parahaemolyticus to investigate the regulation of indigoidine production 
in liquid culture with these additional vibrio strains (Figure 13). A monoculture of Leisingera sp. 
JC1 and JC1 co-cultured with each of the vibrio strains was extracted using the centrifugation 
method and indigoidine production was quantitated via HPLC. Controls included monocultures of 
each vibrio strain that were extracted to confirm the vibrio strains were not producing indigoidine. 
Leisingera sp. JC1 co-cultured with V. fischeri demonstrated a 1.38 fold upregulation of 
indigoidine production. Conversely, JC1 co-cultured with V. anguillarum and V. parahaemolyticus 
exhibited a 0.5 fold down regulation of indigoidine production. The differences in indigoidine 
production were also visually observed in extract pigmentation with a dark blue extract for the co-
culture of JC1 with V. fischeri and pale blue extracts for co-cultures with V. anguillarum and V. 
parahaemolyticus (Figure 13C). No pigmentation was seen in the extracts of each vibrio strain 
(Figure 13A). The upregulation of indigoidine production by Leisingera sp. JC1 in the presence 
of V. fischeri complemented the antibacterial activity exhibited from the in vitro biological assays 
(Figures 10-11), strengthening the hypothesis that indigoidine may contribute to chemical defense 
against V. fischeri. Additionally, the decreased production of indigoidine with V. anguillarum and 
V. parahaemolyticus was consistent with the results from the 96-well liquid assay (Figure 10).  
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Figure 13. Leisingera sp. JC1 upregulates indigoidine production in the presence of V. 
fischeri. JC1 was cultured alone and in the presence of V. fischeri, V. anguillarum, and V. 
parahaemolyticus (each vibrio was also monocultured). (A) Extracts were prepared in DMSO at 
5 mg/mL for LC–MS (from left to right): JC1 monoculture, JC1 + V. fischeri, JC1 + V. 
anguillarum, JC1 + V. parahaemolyticus, V. fischeri monoculture, V. anguillarum monoculture, 
and V. parahaemolyticus monoculture. As shown, the highest pigment production was observed 
when JC1 was co-cultured with V. fischeri. (B) LC–MS UV chromatograms (299 nm) for all 
extracts. JC1 indigoidine production was upregulated when co-cultured with V. fischeri (red). 
Down regulation was observed when co-cultured with V. anguillarum or V. parahaemolyticus 
(green and pink, respectively). (C) Following extraction, indigoidine production was measured 
using HPLC and quantitated via measurement of the area under the curve for UV absorption at 
299 nm. Fold change was calculated as compared with JC1 monoculture.  
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Conclusions 
The Hawaiian bobtail squid and squid egg clutches are consistently interacting with an 
abundance of environmental microorganisms including vibrio species (Mc-Fall Ngai, 2014; 
Urakawa and Rivera, 2006). Although indigoidine was not solely responsible for the antimicrobial 
properties of Leisingera sp. JC1, the differential biological activity observed against the vibrio 
strains through in vitro biological assays (Figure 10 and 11) and increased production of 
indigoidine in co-culture (Figure 13) likely contribute to the defense of squid eggs. In addition, the 
light organ is in close proximity to the ANG, yet the light organ symbiont, V. fischeri, has not been 
detected in the ANG (Collins et al., 2012). Thus, Leisingera sp. JC1 and other bacteria associated 
with the ANG may produce secondary metabolites to prevent V. fischeri, from colonizing in the 
ANG.  
This study confirmed Leisingera sp. JC1, bacterial symbiont associated with E. scolopes, 
produces indigoidine. Whole genome sequencing of JC1 identified the indigoidine biosynthetic 
gene cluster, supporting the confirmation of indigoidine production. Leisingera sp. JC1 and 
extracts from this isolate were shown to differentially inhibit marine vibrios through in vitro 
assays. Interestingly, the normal extract (resin-based) demonstrated more potent inhibition against 
V. fischeri than the indigoidine enriched extract suggesting indigoidine may not be solely 
responsible for the biological activity. Moreover, ZOI assays and co-culturing of JC1 with V. 
fischeri demonstrated localization and upregulation of indigoidine production, suggesting 
indigoidine may contribute to the protective role for squid eggs. Future research will include 
further characterization of secondary metabolites from Leisingera sp. JC1, investigating the 
normal extract (resin-based) and indigoidine enriched extract for leucoindigoidine, and exploring 
additional ANG bacteria to shed light on their potential role in the squid-vibrio symbiosis. 
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Experimental 
Bacterial Isolation 
Euprymna scolopes, Hawaiian bobtail squid, was collected from sand flats in Maunalua 
Bay, Oahu, Hawaii (21o16′ 51.42′′ N, 157o 43′ 33.07′′ W) and maintained in aquaria as previously 
described (Schleicher and Nyholm, 2011). Eggs laid in captivity from one adult female were 
collected, flash frozen on the 11th day of development, and stored at -80 oC. Ten eggs were thawed 
for bacterial isolation and their outer capsules and embryos were removed and discarded with 
sterile forceps. The JCs were isolated, surface sterilized with 70% ethanol, and rinsed with filter-
sterilized squid Ringers (FSSR, 530 mM NaCl, 25 mM MgCl2, 10 mM CaCl2, 20 mM HEPES, pH 
= 7.5). The 10 JCs were pooled and homogenized in FSSR, then serially diluted and plated on 
seawater tryptone medium (SWT; 5 g/L tryptone, 3 g/L yeast extract, 3 mL/L glycerol, 700 mL/L 
Instant Ocean sea salts, 15 g/L agar, 300 mL/L DI water). Leisingera sp. JC1 colonies appeared 
dark blue on this medium and were streaked to isolation.  
 
Leisingera sp. JC1 large scale culture 
Leisingera sp. JC1 was cultured in seawater tryptone media (SWTng; 5 g/L tryptone, 3 g/L 
yeast extract, 700 mL/L Instant Ocean sea salts, 300 mL/L deionized water) using a three step 
process optimized for the production of secondary metabolites (Ruiz et al., 2010). Briefly, small 
scale cultures were prepared in a 24 deep well plate by inoculating a JC1 colony into 5 mL of 
media. Then, medium scale cultures were prepared by transferring 1.5 mL of the small scale 
cultures into 125 mL baffled flasks with 50 mL media. Lastly, large scale cultures were prepared 
by transferring 15 mL of medium scale cultures into 1 L baffled flasks with 500 mL of media. 
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Each culture was incubated for 3 days at room temperature while shaking at 125 rpm with the 
exception of the small scale cultures that shook at 200 rpm.  
 
Extraction of Leisingera sp. JC1 
All solvents used for extraction were ACS grade and purchased from Sigma Aldrich (St. 
Louis, MO, USA).  
Normal Extraction: Leisingera sp. JC1 large scale culture was sonicated to lyse cells and 
Diaion HP20 resin (Supelco, Bellefonte, PA, USA) was pre-washed with methanol followed by 
Millipore water (EMD Millipore, Billerica, MA, USA). The pre-washed resin (10% w/v) was 
added to the bacterial culture and allowed to incubate overnight at room temperature while shaking 
at 125 rpm. The culture and resin were transferred to a coarse glass filter and washed with Millipore 
water (2 x 150 mL) to remove media components and aqueous material. Subsequently, the resin 
was sequentially extracted with methanol, dichloromethane, and acetone (2 x 150 mL). The 
organic portions were combined, concentrated in vacuo, and extracted using ethyl acetate to 
remove any remaining aqueous material.   
Indigoidine-enriched Extraction: Because indigoidine is poorly soluble in water and most 
organic solvents a different extraction method was used from literature with the following 
modifications (Yu et al., 2013).  Leisingera sp. JC1 large scale cultures were sonicated to lyse 
cells, transferred to centrifuge tubes, and the cells were separated from the supernatant using low 
centrifugation (850 g x 5 min; Beckman Coulter Avanti J-E Centrifuge, Brea, CA, USA). Then, 
the supernatant was transferred to new centrifuge tubes and subjected to high centrifugation 
(20,000 g x 10 min) to obtain an indigoidine pellet. The pellet was washed with methanol, 
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transferred to a microcentrifuge tube, dried under N2 gas, and dissolved in dimethyl sulfoxide 
(DMSO).  
 
Detection of Indigoidine Production by Leisingera sp. JC1 via LC-MS 
All solvents used were HPLC grade purchased from Sigma Aldrich. LC-MS data was 
collected on an Agilent ESI single quadrupole mass spectrometer coupled to an Agilent HPLC 
system with a G1311 quaternary pump, G1322 degasser, and a G1315 diode array detector. 
Indigoidine enriched samples were prepared at 5 mg/mL in DMSO and analyzed using a linear 
solvent gradient of 10% methanol in water to 90% methanol over 25 min on an Eclipse XDB-C18 
(4.6 × 150 mm, 5 μm) RP-HPLC column. Indigoidine eluted at 10.7 min in agreement with 
literature (Yu et al., 2013).  
 
96-well Liquid Assays 
Leisingera sp. JC1 extracts were tested for antimicrobial activity against V. fischeri ES114, 
V. anguillarum 775, and V. parahaemolyticus KNH1. Development of these assays were based 
upon growth curves, obtaining CFU counts, incubation temperature, endpoints, and determining 
proper positive controls. These bioassays were performed according to Clinical and Laboratory 
Standards Institute (CLSI) [formerly National Committee for Clinical Laboratory Standards 
(NCCLS)] M07-A9) in 96-well plates (Corning Costar, Kennebunk, ME, USA) with the 
following modifications. Each bacterial isolate was grown on SWT agar at 28 oC. Bacterial inocula 
was prepared by adding select colonies into 5 mL of SWT media and adjusted to an OD600 0.08-
0.13, equivalent to 0.5 McFarland Standard (approximately 1 x 108 CFU/mL).  
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The bioassay was optimized for natural product extracts and the Leisingera sp. JC1 extracts 
were screened as previously described (Zgoda and Porter, 2001) with the following modifications. 
Briefly, master mix was prepared by the addition of 1.6 mL adjusted bacterial inoculum, 7.84 mL 
sterile water, and 6.4 mL of SWT media. Each well consisted of 198 μL of master mix and either 
2 μL of positive control (chloramphenicol, final testing concentration 2.5 μg/mL), negative control 
(DMSO), or extract prepared in DMSO (screened at a final concentration of 500 μg/mL; MIC 
performed using serial dilutions). Sterility control wells consisted of: 98 μL sterile water, 100 μL 
of media, and 2 μL of DMSO. All of the controls and samples were tested in technical triplicates 
and repeated in at least three biological replicates to confirm results. Plates were incubated at 28 
oC while shaking at 200 rpm and read at 600 nm every 2 h from 0-10 h with a final reading at 24 
h using a Syngery H1 Hybrid Reader (Biotek, Winooski, VT, USA). Percent control activity (PCA) 
calculated in comparison to the negative control (DMSO).  
 
Zone of Inhibition Assays 
Leisingera sp. JC1 was tested for a zone of inhibition against V. fischeri ES114, V. 
anguillarum 775, V. parahaemolyticus KNH1, V. harveyi B392, and Photobacterium leiognathi 
KNH6. Each vibrio strain was cultured at 30 oC in YTSS broth (4 g/L tryptone yeast extract, 2.5 
g/L yeast extract, 15 g/L Instant Ocean sea salts) until stationary phase (2.5 h) followed by serial 
dilutions from 107-104 CFU/mL using YTSS broth to evaluate density dependent inhibition. Each 
dilution was spread evenly onto YTSS agar to form a lawn and tested in triplicate. Leisingera sp. 
JC1 was cultured overnight in YTSS to a density of approximately 1 x 108 CFU/mL. Then, 10 μL 
of the overnight culture was aliquoted onto each lawn in quadruplicate. The controls included 10 
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μL of media control aliquoted onto each lawn and 10 μL of Leisingera sp. JC1 aliquoted in 
quadruplicate onto YTSS agar without vibrio strains present as a growth control.  
 
Localization of Indigoidine Production by Leisingera sp. JC1 Using DART-MS 
Direct analysis in real time mass spectrometry (DART-MS) data was performed on an 
AccuTOF (JEOL) with DART ion source (IonSense, Inc., Saugus, MA, USA). High purity helium 
5.0-6.0 grade (greater than 99.999% purity) was heated to 300 oC and used for ionization. Five 
locations were selected on JC1 colonies in the presence or absence of V. fischeri, including (A) 
center of colony, (B) midpoint between center and edge of colony, (C) edge of colony, (D) ZOI 
(in the absence of V. fischeri sample was obtained from a point equidistant from colony edge), and 
(E) outside ZOI. At each location a sterile syringe needle (BD Medical, Franklin Lakes, NJ, USA) 
was placed in the sample and then placed between the DART ion source and MS inlet. Positive 
ion MS were obtained over a m/z range of 60-700 and relative percent abundance was obtained for 
the indigoidine ion. Standards were run after sampling each colony and mass spectral data were 
monitored in real time to ensure no residual indigoidine remained after each sample. DART-MS 
is only semi-quantitative due to the potential for differential ionization, suppression of ions, and/or 
changes in sample concentration in the DART ion source (Sanchez et al., 2011). 
 
Measurement of Indigoidine Production by Leisingera sp. JC1 in Co-culture 
Bacterial inoculum was prepared by adding select JC1 bacterial colonies into 5 mL of 
SWTng media in a 24 deep well plate and allowed to incubate for 24 h at room temperature while 
shaking at 200 rpm. Bacterial inocula for vibrios were prepared by adding select bacterial colonies 
of each species separately into 5 mL of SWTng media in 24 deep well plates, incubated for 2 h at 
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28 oC while shaking at 200 rpm. All bacterial inocula (JC1, V. fischeri, V. anguillarum, and V. 
parahaemolyticus) were adjusted to OD600 0.1 before addition to co-cultures.  
Co-cultures of JC1 with individual vibrios were prepared by adding 1 mL of adjusted JC1 
inoculum to 10 mL SWTng media in 125 mL baffled flasks, incubated for 24 h at room temperature 
while shaking at 125 rpm, followed by addition of 200 μL of V. fischeri, V. anguillarum, or V. 
parahaemolyticus. After addition of the vibrio strain, co-cultures were incubated for an additional 
24 h at room temperature while shaking at 125 rpm. Monocultures of JC1, V. fischeri, V. 
anguillarum, and V. parahaemolyticus were prepared by adding 1 mL of adjusted inoculum to 10 
mL SWTng media in 125 mL baffled flasks, incubated for 48 h while shaking at 125 rpm.  
All co-cultures and monocultures were extracted using the indigoidine enriched protocol 
described above. LC-MS data was obtained on the Agilent LC-MS system described above, using 
an isocratic method to minimize baseline variation (10% acetonitrile in H2O with 0.1% formic acid 
over 15 min at a flow rate of 1 mL/min with 20 μL injection volume). Extracts were prepared at 5 
mg/mL in DMSO. Indigoidine was detected and quantitated via measurement of area under the 
curve at UV absorbance 299 nm and confirmed by MS.  
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Chapter III:  Bacteria Associated with the Hawaiian Bobtail Squid Protect Eggs from Fungal 
Fouling 
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Introduction  
 The eggs and larvae of marine organisms are exposed to numerous microorganisms in the 
ocean (Goecke et al., 2010). In this competitive environment, cephalopod egg clutches should be 
vulnerable to fouling and biofilm formation due to lack of parental care (Lee et al., 2009). Despite 
this, the eggs protect themselves from biofouling or predation during their embryonic development 
period which can range from several weeks to months (Benkendorff et al., 2001; Montgomery and 
McFall-Ngai, 1993). Therefore, eggs may rely on mechanisms such as chemical defense to ensure 
successful development (Benkendorff et al., 2001).  
In some cephalopods, one potential mechanism for egg defense may be associated with the 
accessory nidamental gland (ANG), a reproductive organ present in female cephalopods, that 
contains a diverse bacterial community (Kerwin and Nyholm, 2017; Collins et al., 2012). Although 
the bacterial community of the ANG seems to vary among cephalopod species, 
Alphaproteobacteria, Gammaproteobacteria, and Verrucomicrobia remain the dominant classes 
of bacteria (Kerwin and Nyholm, 2017; Pichon et al., 2005; Collins et al., 2012). Bacteria from the 
ANG are hypothesized to be added to the squid egg jelly coat (Figure 14B-C), yet the functional 
role of the ANG and associated bacteria is poorly understood. Several proposed hypotheses for the 
function of the ANG bacteria in eggs are participation in egg capsule formation (Buchner, 1965) 
or protection of the developing embryos through bioactive secondary metabolite production 
(Pichon et al., 2005; Barbieri et al., 1997; Biggs and Epel, 1991). 
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Figure 14. Antibiotic treatment of squid egg clutches resulted in biofilm formation. (A) 
Ventral dissection of Euprymna scolopes representing the close association of the nidamental 
gland (NG), accessory nidamental gland (ANG), and light organ (LO). (B-C) Enlarged diagram 
representing the ANG bacteria being deposited in the egg JC layers. (D-F) Squid egg clutches not 
treated with antibiotics had the presence of bacteria in the JC layers. (G-H) Squid egg clutches 
treated with antibiotics resulted in biofilm formation. (J) The biofilm was primarily composed of 
a fungal isolate identified as Fusarium keratoplasticum. (K) In addition to the fungus, bacterial 
cells were also found in the biofilm. (I) Electron micrograph images of antibiotic treated egg 
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clutches confirmed the presence of fungal spores infiltrating the JC layers. (L) Egg clutches treated 
with antibiotics for three days eliminated 98% of the bacteria within the egg JC. However, in both 
untreated and antibiotic treated egg clutches the abundance of bacteria increased throughout 
embryogenesis. [Dr. Allison Kerwin obtained data and generated figure.] 
 
Investigating the function of bacterial symbionts such as the ANG bacteria in a host-
microbe system is difficult (Lopanik, 2014). While the composition of the bacterial community 
can be determined from 16S rRNA amplicon sequencing, studying interactions between its 
microbial community using traditional culturing techniques is difficult because there may be 
bacteria represented through sequencing that are unable to be cultured in laboratory conditions 
(Wilson and Piel, 2013). Because there is increased bacterial diversity identified using 16S rRNA 
amplicon community profiling, studying the relationship between the microbial symbionts and 
their host are commonly based on identifying patterns and formulating hypotheses through 
correlative studies as opposed to testing experimentally (Feldhaar, 2011). For example, correlative 
studies have been performed with the accessory bacteria from pea aphids (Acyrthosiphon pisum) 
to evaluate if there is a specific bacterium responsible for the potential resistance to the parasitoid 
wasp (Aphidius eadyi) and fungal pathogen (Pandora neoaphidis) (Ferrari et al., 2004).  
In order to reduce the complexity of host-microbe systems, researchers need tractable 
experimental models such as the Hawaiian bobtail squid (McFall-Ngai, 2014). The binary 
symbiosis of the bioluminescent bacterium V. fischeri in the squid light organ has been studied for 
over 25 years (McFall-Ngai, 2014; McFall-Ngai and Ruby, 1991). Prior research has found these 
squid are easily maintained in aquaria and the ANG bacterial composition remains stable 
throughout embryonic development in captivity (Kerwin and Nyholm, 2017; Lee et al., 2009). 
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Therefore, the Hawaiian bobtail squid can be utilized as a model system to investigate function of 
the ANG bacteria.  
In the current chapter, the functional role of bacteria associated with the ANG of E. 
scolopes was investigated through chemical ecology, comparative metabolomics, and secondary 
metabolite characterization. Several in vivo experiments were performed with squid egg clutches 
including treating the eggs with antibiotics to eliminate bacteria in the eggs to investigate the 
potential protective role of the ANG associated bacteria against environmental fungal pathogens. 
In addition, individual eggs were dissected into various components to discern the antimicrobial 
properties associated with the JC bacterial community. Since the JC has a diverse array of bacteria, 
ANG and JC bacterial isolates were cultured, extracted, and evaluated using in vitro biological 
assays to identify specific bacteria that may be responsible for the antimicrobial activity. Lastly, 
comparative metabolomics was used to investigate secondary metabolites associated with ANG 
and JC bacteria that may be induced in the presence of a fungal pathogen. 
 
Results and Discussion 
Antibiotic treatment of eggs leads to fungal fouling 
To investigate the role of the JC bacterial community, egg clutches were treated with 
antibiotics (either chloramphenicol or an antibiotic cocktail) (Figure 14G-I) eliminating 98% of 
the bacteria within the egg JC after three days (Figure 14L). The egg clutches treated with 
antibiotics developed a biofilm primarily composed of fungal hyphae (Figure 14J-K). In 
comparison, untreated clutches subjected to the same conditions did not develop a biofilm 
suggesting the production of defensive secondary metabolites by the JC bacteria (Figure 14D-F). 
Antibiotic treated and untreated eggs were also subjected to conditions that did not promote fungal 
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growth to determine the effect of antibiotic treatment on embryonic development (Appendix B1). 
These conditions included cooler temperatures ranging from 15-20 °C (Kerwin, personal 
observation) or sterile conditions.  Both the antibiotic treated and untreated eggs maintained at 
cooler temperatures and under sterile conditions exhibited similar hatch rates. Furthermore, 
juveniles were able to successfully colonize Vibrio fischeri, the light organ symbiont, indicating 
that antibiotic treatment did not significantly affect embryonic development or colonization of V. 
fischeri in the light organ after hatching.  
The fungal isolate from the biofilm was analyzed via multilocus sequence typing and 
determined to be Fusarium keratoplasticum, haplotype FSSC-2g, originating from the Fusarium 
solani species complex (FSSC).  Similar to the experiment discussed above, a different set of squid 
egg clutches were treated with antibiotics and maintained in flowing Hawaiian seawater. The eggs 
also developed a biofilm primarily composed of F. keratoplasticum suggesting this fungus is also 
found in the natural environment. The fungus from the Hawaiian biofilm was identified as F. 
keratoplasticum haplotype FSSC-2i, closely related to F. keratoplasticum FSSC-2g (Connecticut 
lab isolate). The Fusarium genus comprises filamentous fungi with at least 45 phylogenetically 
distinct species within the FSSC, and members of this genus are known to infect plants (Coleman, 
2016), immunocompromised humans (O’Donnell et al., 2008; O’Donnell et al. 2010), and marine 
organisms (Fisher et al., 2012). A majority of the Fusarium species within this complex are known 
to be resistant to antifungal drug treatments especially azoles (Al-Hatmi et al., 2017) and thus 
amphotericin B is frequently used to combat fusarial infections.  
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Symbiont-containing jelly coat is protective against fungal fouling 
In another experiment squid eggs were dissected into their various components to 
determine if the JC bacterial community or embryonic host factors may be responsible for 
inhibition of fungal fouling (Figure 15). The eggs in this experiment were not subjected to 
antibiotic treatment so the bacteria remained viable and capable of producing antimicrobial 
compounds. The whole egg, JC and yolk sac, and yolk sac were challenged with F. 
keratoplasticum FSSC-2g. Towards the end of embryonic development (by day 18 of 
embryogenesis) there were fungal hyphae observed on the whole eggs, but the embryos remained 
unaffected (Figure 15A-B). There were similar results for the eggs that had the outer capsule 
removed, leaving the JC and its bacterial community intact (Figure 15C-D). However, removal of 
the outer capsule and JC resulted in fungal growth, preventing embryonic development (Figure 
15E-F). The results suggest the JC and associated bacteria may be responsible for the antifungal 
activity. 
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Figure 15. Euprymna scolopes embryos are susceptible to fungal fouling after removal of the 
jelly coat. (A/C/E) Squid eggs remained untreated or (B/D/F) were challenged with F. 
keratoplsaticum FSSC-2g. Three different components were tested for fungal fouling: (A-B) intact 
eggs, (C-D) the outer capsule was removed exposing the jelly coat and embryo, (E-F) the outer 
capsule and jelly coat were removed exposing the embryo. (F) The fungus was stained with Syto9 
and observed using a confocal microscope. Yellow arrows highlight fungal hyphae. [Dr. Allison 
Kerwin obtained data and prepared figure.] 
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Symbiotic bacteria and their metabolites inhibit fungi 
 
Tissue homogenates of the ANG and JC were serially diluted, plated onto agar, and bacteria 
with unique morphology and pigmentation were isolated for further analysis. Select ANG and JC 
bacterial isolates were cultured, extracted, and tested in a 96-well assay against three 
phylogenetically related F. keratoplasticum strains, FSSC-2i (Hawaiian isolate), FSSC-2g 
(Connecticut lab isolate), and FSSC-2d (human clinical strain) to investigate the possible 
production of antifungal secondary metabolites by the ANG and JC bacteria (Figure 16). F. 
keratoplasticum strains FSSC-2i and FSSC-2g were isolated from antibiotic treated egg clutches. 
In contrast, F. keratoplasticum FSSC-2d was obtained from a lab in Texas and isolated from a 
human cornea. After evaluating 33 ANG and JC bacterial extracts, over half of the extracts were 
able to reduce at least 50% of the fusarial growth. More specifically, eight of these extracts 
demonstrated strong inhibition (≤ 25% fungal growth), and nine additional extracts exhibited 
moderate inhibition (26-50% fungal growth). Furthermore, five extracts displayed minimal 
inhibition (51-75% fungal growth) against at least one F. keratoplasticum strain (Figure 16).  
The ANG and JC bacterial extracts were also tested against Candida albicans (Figure 16), 
a commensal yeast organism in healthy individuals but an opportunistic pathogen in 
immunocompromised patients (Kim et al., 2011). The results suggest that ten out of 33 extracts 
inhibited at least 50% fungal growth against C. albicans. There were five extracts that exhibited 
strong inhibition and five additional extracts that demonstrated moderate inhibition. Additionally, 
one extract displayed minimal inhibition. Several ANG and JC bacterial extracts either inhibited 
C. albicans (e.g. Leisingera sp. M6, Leisingera sp. JC1, Leisingera sp. M7, Leisingera sp. ANG1) 
or Fusarium spp. (e.g. Ruegeria sp. R, Ruegeria sp. ANG10, Pseudoalteromonas sp. JC22, and 
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Alteromonas sp. JC21). These results suggest that ANG and JC bacterial extracts demonstrate 
potent and selective activity against F. keratoplasticum and C. albicans.   
 Although there were six bacterial extracts that were able to inhibit at least 50% fungal 
growth against all F. keratoplasticum strains, several extracts demonstrated selective activity by 
inhibiting one or two strains (Figure 17C). There were also a greater number of extracts that either 
had strong or moderate inhibition against the two environmentally-related F. keratoplasticum 
strains, FSSC-2i and FSSC-2g, isolated from the egg clutch biofilm (Figure 17B). One possibility 
is that the presence of F. keratoplasticum FSSC-2i and FSSC-2g in the surrounding environment 
caused the ANG and JC bacteria to produce specific defensive metabolites against those two fungal 
pathogens, although this remains to be tested.     
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Figure 16. ANG/JC bacterial extracts demonstrate differential activity against fungal 
pathogens. Bacterial extracts were tested against three Fusarium keratoplasticum strains and 
Candida albicans, a human fungal pathogen. Overall, eight out of 33 bacterial extracts 
demonstrated potent activity (≤25% fungal growth) and more than half of the bacterial extracts 
exhibited moderate antifungal activity (≤50% fungal growth) against at least one F. 
keratoplasticum strain. Additionally, five out of 33 extracts had strong inhibition against C. 
albicans.  Amphotericin B was used as the positive control at 4 µg/mL and 2.5 µg/mL against 
Fusarium sp. and Candida sp., respectively. Data shown are average % growth values of technical 
triplicates from at least two biological experiments.  
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Figure 17. ANG/JC bacterial extracts demonstrate differential antifungal activity against the 
three phylogenetically related F. keratoplasticum strains. (A) There were a greater number of 
extracts with either strong or moderate inhibition against the environmentally-related F. 
keratoplasticum strains, FSSC-2i and FSSC-2g, isolated from squid eggs whereas fewer extracts 
were found to be active against the environmentally-unrelated F. keratoplasticum strain FSSC-2d. 
(B) Six bacterial extracts were able to inhibit at least 50% fungal growth against all three F. 
keratoplasticum strains. In contrast, several extracts demonstrated selective activity against only 
one or two strains.  
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Prior studies suggest that bacterial symbionts associated with invertebrates demonstrate the 
ability to prevent fungal fouling.  In Palaemon macrodactylus (caridean shrimp) an Altermonas 
sp. bacterium was isolated from the surface of larvae and subsequently shown to produce 2,3 
indolinedione (isatin) (Gil-Turnes et al., 1989). In vivo studies suggested that treatment of these 
larvae with either Altermonas sp. culture or isatin inhibited colonization of Lagenidium callinectes, 
a common marine fungal pathogen (Gil-Turnes et al., 1989). Another bacterium was isolated from 
the embryos of Homarus americanus (American lobster) and found to produce 4-
hydroxyphenethyl alcohol (tyrosol) that also demonstrated inhibition of L. callinectes (Gil-Turnes 
and Fenical, 1992). Symbiont mediated egg defense has also been observed in Lagria villosa 
(beetles) coating their eggs in Burkholderia sp. This bacterium produces two compounds, 
caryoynecin and sinapigladioside, that inhibit Purpureocillium lilacinum (Flórez et al., 2018; 
Flórez et al., 2017). Fungal defense by symbiotic bacteria has also been displayed in the association 
of Plethodon cinereus (red-backed salamander) with Janthinobacterium lividum, a bacterium that 
produces the antifungal metabolites, violacein and indole-3-carboxaldehyde, inhibiting the growth 
of Batrchochytrium dendrobatis (Harris et al., 2009). Thus, the production of secondary 
metabolites by ANG and JC bacterial isolates to protect the eggs from fungal fouling is consistent 
with the observation that use of defensive symbionts against pathogens is a common strategy in 
marine and terrestrial organisms.  
 
Induction of bacteria associated with squid eggs reveals secondary metabolites 
 
Comparative metabolomics was used to explore antifungal secondary metabolites 
associated with the JC bacteria that may be induced in the presence of F. keratoplasticum. For this 
experiment, an egg clutch was divided into two portions. One portion was challenged with 104 bud 
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cells/mL of F. keratoplasticum FSSC-2g (yellow arrow) and the other portion remained untreated 
as a control (blue arrow) (Figure 18A). The egg clutch in this experiment was not subjected to 
antibiotic treatment therefore leaving the JC bacteria remained viable and capable of producing 
metabolites. LC-MS/MS molecular networking identified two clusters with metabolites only 
present in the egg clutches challenged with F. keratoplasticum FSSC-2g (yellow circles) (Figure 
18B). Further investigation of the first molecular cluster revealed three possible mycinamicin-like 
derivatives (III, IV, and VI). The putative identification of mycinamicin-like derivatives was 
compared to authenticated standards. Upon further examination of the raw LC-MS/MS data, there 
were in-source fragments consistent with the desosamine moiety in mycinamicins. However, 
additional analyses of the challenged egg clutch extract and authenticated standards via LC-
MS/MS displayed a difference in retention time that suggests the compounds within this cluster 
may be more closely related to glycerophosphocholines. There are ongoing efforts to identify and 
characterize the compounds within this cluster including investigating the effects on retention time 
from the gelatinous JC.   
The mycinamicins are 16-membered macrolides with D-desosamine and D-mycinose 
sugars originally isolated from an actinomycete Micromonospora griseorubida (Satoi et al., 1980; 
Hayashi et al., 1983; Hayashi et al., 1981). This class of compounds has been well studied due to 
the strong biological activity against gram positive bacteria (Satoi et al., 1980). Macrolides are 
members of the polyketide class of natural products and are commonly composed of 14-,15-, or 
16-membered macrocylic lactone rings with one or more sugars attached to the core lactone 
structure (Zuckerman, et al. 2011). Prior studies demonstrated that a majority of macrolides inhibit 
protein synthesis by binding to the 23S rRNA of the 50S bacterial ribosomal subunit (Zuckerman, 
et al. 2011; Schluzen et al., 2001). The D-desosamine sugar associated with macrolides has been 
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shown to have selectivity to bacterial ribosomes due to key hydrogen bonding interactions with 
the 2'-OH and dimethylamino group in the binding site (Schluzen et al., 2001). Within the 
mycinamicin-like molecular cluster there are three additional nodes with similar MS/MS 
fragmentation patterns indicating the potential for structurally similar analogues. Three 
mycinamicin standards, III, IV, and VI, were kindly provided by the laboratory of Dr. David 
Sherman (University of Michigan) and tested in the 96-well assay against F. keratoplastium FSSC-
2g. Mycinamicins IV and VI demonstrated minimal inhibition with 73.4 % growth and 68.6 % 
growth, respectively, and mycinamicin III had no antifungal activity.  
In the second molecular cluster of interest, two glycerophosphocholines, lyso-PAF C:16 
and lyso-PAF C:18 were initially identified from a database search, but ultimately found to slightly 
differ from lyso-PAF C:16 and C:18. Purchased standards of lyso-PAF C:16 and C:18 as well as 
a structural analogue PC 18:1/0:0 were tested in the 96-well assay against F. keratoplasticum 
FSSC-2i and FSSC-2g. Lyso-PAF C:16 and lyso-PAF C:18 demonstrated weak antifungal activity 
both with minimum inhibitory concentration (MIC) values of 125 µg/mL, while PC 18:1/0:0 
exhibited more potent antifungal activity with MIC value of 31.3 µg/mL. PC 18:1/0:0 may 
demonstrate stronger antifungal activity due to the unsaturation in the fatty acid tail causing more 
effective penetration of the fungal cell membrane (Steinbuch et al., 2018). Additional 
glycerophosphocholine derivatives were identified in challenged clutches, control clutches, and/or 
fungal extract (Figure 18B). However, the lyso-PAF compounds present in challenged clutches 
appear to be structurally distinct from the additional glycerophosphocholines identified in the 
network (Table 1).  
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Figure 18. Induction of secondary metabolites produced by bacteria associated with egg 
clutches in the presence of Fusarium keratoplasticum. (A) An egg clutch was separated into two 
portions. One portion was treated with F. keratoplasticum FSSC-2g and the other portion remained 
untreated as a control. The egg clutch was not treated with antibiotics therefore allowing the 
bacteria associated with the egg clutches capable of biosynthesizing antifungal secondary 
metabolites. (B) LC-MS/MS molecular networking identified two clusters with metabolites only 
present in egg clutches challenged with F. keratoplasticum FSSC-2g (yellow circles). 
Furthermore, additional metabolites were found in control clutches (blue circles) and F. 
keratoplasticum FSSC-2g (grey circles). Parent masses are represented within each node and the 
thickness of the edge is based upon cosine similarity score.  
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Table 1. Additional phosphocholines identified through the GNPS database from 
challenged clutches, control clutches, and Fusarium keratoplasticum FSSC-2g extracts. 
 
 
 
Putative 
Identification Sample 
Node 
massb 
Observed  
m/z 
[M+H]+ c 
Theoretical  
m/z [M+H]+ 
Mass 
accuracy 
(ppm) 
PC 0:0/14:0 Challenged clutches 468.231 468.3049 468.3085 7.6 
PC 15:0/0:0 Challenged clutches 482.258 482.3198 482.3241 8.9 
PC 16:1/0:0 Challenged clutches 494.256 494.3265 494.3241 4.8 
PC 0:0/18:1d Challenged clutches 522.291 522.3575 522.3554 4.0 
PC 18:2/0:0 
F. keratoplastiucum 
FSSC-2g 520.276 520.3347 520.3398 9.7 
PC 18:3/0:0 
F. keratoplastiucum 
FSSC-2g 518.259 518.3257 518.3252 0.9 
PC 17:0/0:0d 
Challenged and 
control clutches 510.290 510.3581 510.3554 5.3 
PC 17:0/0:0d 
Challenged and 
control clutches 510.290 510.3581 510.3554 5.3 
PC 20:1/0:0 
Challenged and 
control clutches 550.321 550.3832 550.3867 6.4 
PC 17:0/0:0d 
Challenged and 
control clutches 510.298 510.3581 510.3554 5.3 
PC 0:0/18:0 
Challenged and 
control clutches 524.308 524.3744 524.3711 6.4 
PC 0:0/16:0 All 3 496.268 496.3372 496.3398 5.2 
PC 0:0/18:1d All 3 522.291 522.3575 522.3554 4.0 
a features could represent one of several related isomers 
b consensus mass generated through GNPS 
c experimental spectra obtained using Waters Synapt G2-Si, processed with MassLynx V4.1 
d several nodes with similar masses were found in this cluster, likely representing isomers 
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Platelet activating factors (PAFs) are potent biological mediators primarily produced by 
cells involved in host defense (Sohlenkamp et al., 2003). These molecules are converted to lyso-
PAF by removing an acetyl group with acetylhydrolase, and lyso-PAF is reverted to PAF with 
acetyltransferase (Quinn et al., 2016; Sohlenkamp et al., 2003). Lyso-PAFs are produced by 
marine invertebrates including sponges (Quinn et al., 2016; Shin et al., 1999) and sea cucumbers 
(Nishikawa et al., 2015). Several of these compounds have been shown to possess antibacterial 
activity against gram positive bacteria (Steel et al., 2002) and antioxidant activity (Nishikawa et 
al., 2015). Previous research suggests that bacterial compounds with a choline moiety (i.e., lyso-
PAFs) are usually in a close relationship, either symbiotic or pathogenic, with a eukaryotic host 
that contributes choline for the biosynthesis of these compounds (Aktas et al. 2010; Sohlenkamp 
et al., 2003). Thus far, lyso-PAF compounds have not been detected in the ANG and JC bacterial 
extracts. However, these lyso-PAF derivatives may be produced by ANG and JC bacteria after 
acquiring choline from the Hawaiian bobtail squid.  
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Conclusions 
 Previous research revealed E. scolopes has an ANG primarily composed of a consortium 
of diverse bacteria, although the function of the organ and the associated bacteria remained poorly 
understood. The results discussed in this chapter reveal that the symbiotic bacteria associated with 
the ANG has a defensive function. Overall, the ANG and JC bacteria demonstrated the ability to 
protect developing embryos against fungal fouling. The presence of an ANG among other 
cephalopods (Kerwin et al., 2018) suggests this defensive function may be conserved. The egg 
clutches treated with antibiotics and dissected egg components challenged with F. keratoplasticum 
FSSC-2g provide evidence that the JC bacterial community may be responsible for protection 
against fungal fouling. The results from the 96-well antifungal assays suggested ANG and JC 
bacterial extracts produce antifungal secondary metabolites that have the ability to inhibit both 
filamentous and yeast fungal pathogens.  
The potent antifungal activity of the ANG and JC bacterial extracts suggest this may be a 
promising source for discovery and development of novel antifungal compounds. Fusarium 
species are widely distributed in soil and are known to infect plants and humans (Coleman et al., 
2006; O’Donnell et al., 2008; O’Donnell et al. 2010). In addition to their impact on human disease, 
FSSC fungi have emerged as marine pathogens, threatening extinction of endangered species 
through their association with developing egg clutches (Fisher et al., 2012). Most importantly, 
there is a need for new antifungal compounds since a majority of the species within the FSSC are 
resistant to current antifungal treatments (O’Donnell et al., 2008).  
Overall, there were a greater number of ANG and JC bacterial extracts that inhibited F. 
keratoplasticum in comparison to C. albicans.  The differential activity may be due to the presence 
of F. keratoplasticum that was isolated from the antibiotic treated egg clutches and therefore 
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present in the natural environment causing the ANG and JC bacteria to adapt and produce specific 
defensive metabolites against F. keratoplasticum spp., although this remains to be investigated in 
future studies. Utilization of comparative metabolomics identified mycinamicin-like and 
glycerophosphocholine analogues that were induced in egg clutches challenged with F. 
keratoplasticum FSSC-2g, and may contribute to symbiont mediated egg defense.  
Although the specific JC bacteria responsible for the production of the mycinamicin-like 
and glycerophosphocholine derivatives was not determined herein, future research should include 
investigating other classes of bacteria represented in the ANG such as Verrucomicrobia and 
Flavobacteria as well as continuing to analyze Proteobacteria that may possess the ability to 
produce these compounds. Some of the ANG and JC bacteria may be difficult to culture under 
laboratory conditions or only produce defensive secondary metabolites through interactions with 
additional members of the JC bacterial community. Therefore, synergistic studies could include 
testing one or more ANG and JC bacterial extracts in the 96-well assay or co-culturing the ANG 
and JC bacterial isolates with F. keratoplasticum.         
 
Experimental  
 
 
Culture and Extraction 
ANG and JC bacterial isolates were cultured in seawater tryptone media (SWT; 5 g/L 
tryptone, 3 g/L yeast extract, 3 mL/L glycerol, 700 mL/L Instant Ocean sea salts, 300 mL/L 
deionized water) using a three step process as previously described. Briefly, small scale cultures 
were prepared in a 24 deep well plate by inoculating select colonies into 5 mL of media. Then, 
medium scale cultures were prepared by transferring 1.5 mL of the small scale cultures into 125 
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mL baffled flasks with 50 mL media. Lastly, large scale cultures were prepared by transferring 15 
mL of medium scale cultures into 1 L baffled flasks with 500 mL of media. Each culture was 
incubated for 3 days at 28 °C while shaking at 200 rpm.  
 
Extraction of ANG and JC bacterial isolates 
All solvents used for extraction were ACS grade and purchased from Sigma Aldrich (St. Louis, 
MO, USA). ANG and JC large scale cultures were extracted as previously described. Briefly, 
cultures were sonicated to lyse cells and Diaion HP20 resin (Supelco, Bellefonte, PA, USA) was 
pre-washed with methanol followed by Millipore water (EMD Millipore, Billerica, MA, USA). 
The pre-washed resin (10% w/v) was added to the bacterial culture and allowed to incubate 
overnight at room temperature while shaking at 125 rpm. The culture and resin were transferred 
to a coarse glass filter and washed with Millipore water (2 x 150 mL) to remove media components 
and aqueous material. Subsequently, the resin was sequentially extracted with methanol, 
dichloromethane, and acetone (2 x 150 mL). The organic portions were combined, concentrated 
in vacuo, and extracted using ethyl acetate to remove any remaining aqueous material.   
 
96-well antifungal bioassays 
Fusarium spp. 
 ANG and JC bacterial extracts were tested for antifungal activity against three Fusarium 
sp. strains, including F. keratoplasticum (FSSC-2i), F. keratoplasticum (FSSC-2g), and F. 
keratoplasticum (FSSC-2d). Fusarium sp. fungal inocula was prepared as previously described 
(Espinel-Ingroff et al. 1999) and the bioassays were performed according to the Clinical and 
Laboratory Standards Institute (CLSI) [formerly National Committee for Clinical Laboratory 
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Standards (NCCLS)] M38-A2 (2008) in 96-well flat bottom plates (Corning Costar, Kennebunk, 
ME, USA) with the following modifications.  
Each fungal isolate was grown on SWT agar supplemented with 50 µg/mL of 
chloramphenicol at 28˚C. The mature fungus was covered with 3 mL of media, probed with a loop, 
and the mixture was transferred into 10 mL of fresh media. The fungal mixture was vortexed, 
allowed to settle, and the cell suspension below hyphae was transferred to a new falcon tube. The 
cell suspension was adjusted to an OD600 0.15-0.17 and diluted 1:50 with media.  
Each well consisted of 100 µL of the diluted fungal inoculum, 98 µL of media, and 2 µL 
of either positive control (amphotericin B, final testing concentration 4 µg/mL), negative control 
[dimethyl sulfoxide (DMSO)], or extract prepared in DMSO (final testing concentration 500 
µg/mL). The extracts and controls were tested in technical triplicates with at least two biological 
replicates to confirm the results. Plates were read on a Synergy H1 Hybrid Reader (Biotek, 
Winooski, VT, USA) at 600 nm at 0 h, incubated at 28˚C, and then read again at 14 h. Percent 
growth was calculated in comparison to DMSO (negative control).   
 
Candida sp. 
ANG and JC bacterial extracts were also tested against a human fungal pathogen Candida 
albicans (ATCC 18804) following CLSI M27-A2 (2008) in 96-well flat bottom plates with the 
following modifications. C. albicans colonies were selected from an agar plate and inoculated into 
5 mL of RPMI media (Gibco®) was supplemented with 2% glucose, and then adjusted to an OD600 
0.08-0.1 followed by a 1:10 dilution with fresh media. Each well consisted of 100 µL of the diluted 
fungal inoculum, 98 µL of media, and 2 µL of either positive control (amphotericin B, final testing 
concentration 2.5 µg/mL), negative control (DMSO), or extract prepared in DMSO (final testing 
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concentration 500 µg/mL). The extracts and controls were tested in technical triplicates with at 
least two biological replicates to confirm the results. Plates were read on a Synergy H1 Hybrid 
Reader at 600 nm at 0 h, incubated at 35 °C, and then read again at 24 h. Percent growth was 
calculated in comparison to DMSO (negative control).   
 
Extraction of intact egg clutches challenged with F. keratoplasticum 2g 
An egg clutch was divided into two portions. One portion was challenged with 104 bud 
cells/mL F. keratoplasticum FSSC-2g for 11 days in filter-sterilized sea water at room temperature 
with water changes and addition of fresh bud cells every two-three days. The second portion 
remained untreated to be used as a control. The egg clutches were not treated with antibiotics. 
Challenged and control egg clutches (5 mL volume each) were separately extracted with 2:1 
DCM:MeOH (7 x 50 mL). Samples were sonicated, manually macerated with a metal spatula, and 
incubated for 10 min at room temperature, after which solvent was filtered, combined, and 
concentrated in vacuo resulting in 50.8 mg and 84.1 mg of challenged clutch extract and control 
clutch extract, respectively. 
 
LC-MS/MS Analyses and Molecular Networking   
Extracts were analyzed via LC-MS/MS using a Synapt G2-Si coupled to an Acquity UPLC 
system with an Acquity UPLC HSS T3 column (2.1 x 150 mm, 1.8 µM) connected to an Acquity 
UPLC HSS T3 VanGuard pre-column (2.1 x 5 mm, 1.8 µM). at a flow rate of 0.45 mL/min. 
Samples were prepared at 1 mg/mL in a 1:1 mixture of methanol/water and linear gradient elution 
was performed at 0.45 mL/min with mobile phases A (water with 0.1% formic acid) and B 
(acetonitrile with 0.1% formic acid) using the following conditions: 0.5 min hold at 95% A (0.1% 
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formic acid in water) and 5% B (0.1% formic acid in acetonitrile), 3.5 min ramp to 60% B, 4 min 
ramp to 98% B, 1 min hold at 98% B, 0.2 min ramp back to 5% B and a re-equilibration hold at 
5% B for 1.8 min.  
 The instrument was operated in positive, resolution mode using the following parameters: 
2 kV capillary voltage, 100 °C source temperature, 20V sampling cone, 800 L/h desolvation gas 
flow, and 80V source offset. Data was obtained using an 11 min Fast data dependent acquisition 
(Fast DDA) method with a 0.1 sec MS survey scan ranging from m/z 50-2000, followed by five 
0.1 sec data-dependent MS/MS scans of ions with intensities greater than 1000 as determined 
during the preceding scan event. Survey scans were acquired without collision energy (CE) and 
MS/MS scans were acquired using a linear two-stage low mass (0-20V) and high mass (10-
40V) CE linear ramp. Lockspray real-time mass correction was turned on to achieve 
optimal mass accuracy by monitoring m/z 556.2771 and m/z 120.0813 ions from simultaneous 
infusion of a 400 pg/µL leucine enkephalin solution (0.1% formic acid in a 50% water, 50% 
methanol solution) with 0.1 sec scans, a 10 sec scan interval and 3 average scans per correction. 
Data was converted to mzML format using ProteoWizard package (Chambers, et al. 2012) 
and processed in GNPS: Global Natural Products Social Molecular Networking 
[http://gnps.ucsd.edu, (Wang et al., 2016)]. The following parameters were selected in GNPS for 
the challenged and control clutch network: minimum cosine similarity score of 0.65 with at least 
four matching peaks; parent mass tolerance of 1.0 Da; fragment ion tolerance 0.02 Da; and filter 
peaks in a 50Da window was turned off. Files were imported into Cytoscape 2.8.3 and nodes 
arranged with FM3 layout (Shannon, et al., 2003).  
Standards and clutch extracts were confirmed using a Waters Xevo G2-XS QToF mass 
spectrometer coupled to a Waters Acquity UPLC. Separations utilized a Waters Acquity UPLC 
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HSS T3 column (2.1 x 50 mm, 1.8 µM, 100Å) connected to an Acquity UPLC HSS T3 VanGuard 
pre-column (2.1 x 150 mm, 1.8 µM, 100Å). Conditions were identical to those described above 
with the exception that MS/MS scans were acquired using a linear two-stage low mass (10-40V) 
and high mass (40-80V) CE linear ramp. The instrument was operated in positive, sensitivity mode 
using the following parameters: 3 kV capillary voltage, 100 °C source temperature, and 30V 
sampling cone. Lockspray real-time mass correction used a simultaneous infusion of a 200 pg/µL 
leucine enkephalin solution.  
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Chapter IV: Chemical Networking Analyses to Identify Secondary Metabolites from 
Labrenzia sp. ANG18, a Bacterial Symbiont 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Significant contributions to this chapter were made by the following researchers. Drs. 
Andrea Suria and Spencer Nyholm, University of Connecticut, isolated the ANG and JC bacteria 
used for culture and extraction and analyzed the genome for Table 2.  
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Introduction 
Bacterial symbionts of host-microbe relationships are emerging as promising sources for 
novel drug discovery due to the potential for the symbionts to produce biologically active 
secondary metabolites that protect the host organism from predators and harmful pathogens (Lin 
et al., 2016; Schmidt et al., 2012; Schmidt et al., 2008). As mentioned in the previous chapters the 
Hawaiian bobtail squid, Euprymna scolopes, can be utilized as a model system to investigate 
biologically active bacteria associated with the accessory nidamental gland (ANG), a female 
reproductive organ. Prior research (Collins et al., 2012) has hypothesized that the ANG works in 
conjunction with the nidamental gland (NG) to deposit bacteria in between the egg JC layers 
(Figure 7). Subsequently, the JC bacteria are hypothesized to produce antimicrobial compounds 
for chemical defense to protect the eggs from fungal fouling, biofilm formation, and/or predators 
during their physically unprotected embryonic period.  
The ANG bacterial community is dominated by bacteria from Alphaproteobacteria, 
specifically from the Roseobacter clade, but also consists of Verrucomicrobia and 
Gammaproteobacteria (e.g., Vibrio and Pseudoalteromonas) (Collins et al., 2015; Collins et al., 
2012). Within the class Alphaproteobacteria is the genus Labrenzia that consists of five species 
typically originating from high salt environments (Schleisnner et al., 2017).  These species are also 
commonly found in marine environments affected by oil spills such as the Deepwater Horizon 
spill (Schleissner et al., 2017; Fiebig et al., 2013). Crude oil is primarily composed of aliphatic and 
aromatic hydrocarbons, and Labrenzia sp. have previously been reported to degrade these 
hydrocarbons (Schleissner et al., 2017; Fiebig et al., 2013). Even though genomic analysis of 
Labrenzia spp. has revealed their biosynthetic potential to produce secondary metabolites 
including polyketides, thiopeptides, and terpenes (Rodrigues et al., 2018), this genus has not been 
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thoroughly investigated for bioactive secondary metabolites. Recently, Labrenzia sp. PHM005 
was isolated from marine sediment near Kenya resulting in the discovery of a novel pederin 
analogue that demonstrated potent cytotoxic activity (Schleisnner et al., 2017). As a result of this 
investigation, as well as the genomic analysis demonstrating substantial biosynthetic potential, 
Labrenzia spp. may be a good source for novel drug discovery.  
In the previous chapter, Labrenzia sp. ANG18, an accessory nidamental gland (ANG) 
bacterial isolate, demonstrated potent antifungal activity against three phylogenetically related F. 
keratoplasticum strains. For the current chapter, a suite of mass spectroscopic and nuclear 
magnetic resonance techniques was used to isolate and identify biologically active constituents of 
Labrenzia sp. ANG18. By integrating comparative metabolomics, biological assays, and microbial 
interactions, defensive secondary metabolites can be prioritized for further analyses. The genome 
of Labrenzia sp. ANG18 was analyzed using antibiotics and Secondary Metabolite Shell 
(antiSMASH) (Weber et al., 2015) to identify known biosynthetic gene clusters.  Lastly, the 
isolation and partial characterization of a peptide produced by Labrenzia sp. ANG18 will be 
discussed.  
 
Results and Discussion 
 
Chemical networking analyses identifies potential antimicrobial metabolites 
 In the previous chapter, bacterial isolates from the ANG and JC were cultured, extracted, 
and tested for antifungal activity against three phylogenetically related F. keratoplasticum strains 
within the Fusarium solani species complex (FSSC) and Candida albicans. The results suggested 
eight of the ANG and JC bacterial extracts demonstrated strong inhibition (≤ 25% fungal growth) 
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against at least one F. keratoplasticum strain. In addition, squid egg clutches were either 
challenged with F. keratoplasticum to induce the production of defensive secondary metabolites 
associated with the ANG and JC bacteria or remained untreated as the control.  
To gain a better understanding of the functional role of the bacteria associated with the 
ANG and identify key antifungal secondary metabolites, a molecular network was generated using 
the challenged clutches, control clutches, ANG and JC bacterial extracts demonstrating potent 
antifungal activity (≤ 25% fungal growth) against at least one F. keratoplasticum strain, and 
bacterial extracts inactive against all three F. keratoplasticum strains (> 76% fungal growth) 
(Figure 19). This molecular network identified features present in both the active bacterial extracts 
and egg clutches (Figure 20). Seven features were identified in both the challenged clutches and 
active extracts (≤ 25% fungal growth) demonstrating the biosynthetic potential of ANG and JC 
bacteria to produce or upregulate antimicrobial metabolites when challenged with a pathogen. 
Furthermore, three features were identified in both the control clutches and active extracts 
suggesting there may be constitutively active metabolites.  
As discussed in previous chapters, bacteria associated with the egg clutches are 
hypothesized to prevent fungal fouling through the production of secondary metabolites. 
Therefore, as shown in Figure 19, compounds produced in active bacterial extracts (blue circles), 
compounds present in both the active ANG/JC bacteria and challenged clutches (pink squares), 
and compounds present in both the active ANG/JC bacteria and control clutch extracts (turquoise 
square) were prioritized for further analyses. One of the consensus nodes with m/z 393.1480 was 
present in an active extract, Labrenzia sp. ANG18, and the control clutches (Figure 20). Because 
we are interested in pursuing compounds that may be constitutively active due to the constant 
exposure of the ANG/JC bacteria to microbial pathogens in the surrounding environment, we 
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sought to identify the molecule and thus Antibase, a natural product database, was used to search 
for the molecular weight. From the database, m/z 393.1480 was putatively identified as lincomycin 
B, a derivative of the FDA-approved antibiotic, lincomycin A. The presence of lincomycin B in 
Labrenzia sp. ANG18 was confirmed via LC-MS/MS using a commercial standard (Figure 21 and 
22).  
 
Figure 19. Utilization of comparative metabolomics to identify key biologically active 
constituents produced by active ANG/JC bacterial extracts and egg clutches. Molecular 
network generated to compare metabolites exclusively present in active ANG/JC bacterial extracts 
(yellow circles; ≤ 25% fungal growth), inactive ANG/JC bacterial extracts (blue circles; > 76% 
fungal growth), and metabolites present in both the active ANG/JC bacteria and challenged 
clutches (pink squares) or metabolites present in both the active ANG/JC bacteria and control 
clutch extracts (turquoise square).   
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Figure 20. Utilization of comparative metabolomics to identify biologically active 
constituents produced by active ANG/JC bacterial extracts and egg clutches. Within the 
network, seven features were found in both the active ANG/JC bacterial extracts and challenged 
clutches, and three features were found in both the active ANG/JC bacterial extracts and control 
clutches (teal squares). Furthermore, there were compounds present in inactive ANG/JC bacterial 
extracts (> 76% growth) (blue circles) and compounds present in both inactive bacterial extracts 
and control clutches and/or solvent (grey squares). Lincomycin B, [M+H]+ 393.1480, was 
produced by an active bacterial extract (Labrenzia sp. ANG18) and the control clutches. The 
compound was confirmed via comparison with a purchased standard using LC-MS/MS. 
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Figure 21. Confirmation of the presence of lincomycin B in the control clutch extract 
including extracted ion chromatogram (EIC) for lincomycin B ([M+H]+ m/z 393.2054, tR 2.79 
min). Lincomycin A was not detected in the control clutches ([M+H]+ m/z 407.2210). Lincomycin 
A and B standards (Santa Cruz Biotechnology, Inc., Dallas, TX) were authenticated using 1H NMR 
and HRMS prior to LC-MS/MS comparison. 
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Figure 22. Confirmation of the presence of lincomycin B in the Labrenzia sp. ANG18 extract 
using LC-MS/MS extracted ion chromatogram for lincomycin B ([M+H]+ m/z 393.2054).  
  
76 
The lincomycins were originally isolated from an actinomycete, Streptomyces lincolnensis 
var. lincolnensis and have been extensively studied for the treatment of Gram-positive bacterial 
infections (Barber and Waterworth, 1964), with lincomycin A receiving FDA approval in 1967. 
Lincomycin biosynthesis involves the separate synthesis of 4-propyl-L-proline (PPL) and 
methylthiolincosamide (MTL), condensation of PPL and MTL to form N-demethyl-lincomycin, 
and methylation by S-adenosylmethionine to lincomycin A (Table 2) (Hou et al., 2018). The PPL 
moiety is also found in additional antibiotics such as hormaomycin and sibiromycin, both produced 
by Streptomyces spp. (Jiraskova et al., 2016).  
  In our 96-well antifungal assay, lincomycin A and B were tested at 250 µg/mL and did not 
inhibit F. keratoplasticum FSSC-2i and FSSC-2g (> 76% fungal growth). However, further 
analyses of Labrenzia sp. ANG18 via LC-MS/MS revealed putative classification of additional 
secondary metabolites that will be discussed below. The identification of lincomycins in Labrenzia 
sp. ANG18 and control egg clutches suggest that defense metabolites may be constitutively active 
to protect the squid eggs from bacterial infection. Furthermore, to our knowledge this is the first 
report of lincomycin derivatives produced by a bacterial isolate within Alphaproteobacteria. 
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Table 2: Basic local alignment search tool (BLAST) analysis of Labrenzia sp. ANG 18 for 
lmb genes. 
Protein Proposed function Query cover 
(%) 
Amino acid identity 
(%) 
BLAST hit 
lmbA Propylproline 99 47 Scaffold 6.1 
lmbB1 Propylproline 64 24 Scaffold 2.1 
lmbB2 Propylproline 29 34 Scaffold 2.1 
lmbC Condensation 81 29 Scaffold 
46.1 
lmbD Condensation 25 31 Scaffold 4.1 
lmbE Condensation 22 28 Scaffold 
28.1 
lmbF Unknown 24 24 Scaffold 
12.1 
lmbG Unknown 26 36 Scaffold 
15.1 
lmbIH Regulation 50 30 Scaffold 3.1 
lmbJ Methylation 42 30 Scaffold 
30.1 
lmbK methylthiollincosaminide 54 34 Scaffold 
33.1 
lmbL Unknown 52 33 Scaffold 3.1 
lmbM Unknown 94 32 Scaffold 
15.1 
lmbN methylthiollincosaminide 28 28 Scaffold 1.1 
lmbZ Unknown 74 28 Scaffold 1.1 
lmbP methylthiollincosaminide 16 34 Scaffold 1.1 
lmbO methylthiollincosaminide 54 34 Scaffold 8.1 
lmbS Unknown 90 32 Scaffold 1.1 
lmbR methylthiollincosaminide 97 29 Scaffold 6.1 
lmbQ Regulation 19 39 Scaffold 3.1 
lmbT Condensation 14 29 Scaffold 
12.1 
lmbV Condensation 16 35 Scaffold 
13.1 
lmbW Propylproline 59 41 Scaffold 3.1 
lmbX Propylproline 94 30 Scaffold 5.1 
lmbY Propylproline 41 25 Scaffold 2.1 
lmbU Regulation 34 41 Scaffold 6.1 
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In addition to the three features that were present in both the active bacterial extracts and 
control clutches, there were seven features produced by both the active bacterial extracts and 
challenged clutches (pink squares) (Figure 20). All of these molecular weights were analyzed 
through the following databases: METLIN (Guijas et al., 2018) (https://metlin.scripps.edu/), 
Global Natural Products Social Molecular Networking (GNPS; 
https://gnps.ucsd.edu/ProteoSAFe/static/gnps-splash.jsp) (Wang et al., 2016), and Marinlit. Any 
compound that was within 20 ppm mass accuracy of the molecular weight was fragmented in silico 
using Mass Frontiers 7.0 (Hill et al., 2008) and the predicted fragmentation patterns were compared 
to the experimental data. To date no known compounds have been identified from these features. 
In the future, the molecular weights should be analyzed in additional natural product databases 
such as Antibase and NP ATLAS (http://www.npatlas.org/joomla/). Also, additional ANG and JC 
bacterial extracts analyzed via LC-MS or LC-MS/MS should be searched for the seven 
compounds.   
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Genome characteristics of Labrenzia sp. ANG18 
 Labrenzia sp. ANG18 has a draft genome size of 6.8 Mb and a GC content of 59% which 
is similar to other Roseobacter isolates (Table 3) (Gromek et al., 2016; Collins et al., 2015). 
Analysis of the genome with antibiotics and Secondary Metabolite Shell (antiSMASH) (Weber et 
al., 2015) revealed the capacity to produce secondary metabolites (Table 3) including homoserine 
lactones, bacteriocin, and ectoine. In addition, a basic local alignment search tool (BLAST) search 
identified lincomycin genes in the genome, supporting the presence of lincomycin B in the 
bacterial extract (Table 2).   
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Table 3. Genome statistics of Labrenzia sp. ANG18 and Antibiotics and Secondary 
Metabolite Analysis Shell (antiSMASH) analysis of biosynthetic gene clusters in Labrenzia 
sp. ANG18. 
 
 
 Genome Size 
(Mb) 
Number 
of 
Contigs 
N50 
(bp) 
G + C 
Content 
(%) 
Fold 
Coverage 
(%) 
6.8 51 371,108 59 9.5 
antiSMASH 
gene cluster 
prediction 
Number 
of 
predicted 
clusters 
Homoserine 
lactone 4 
Bacteriocin 2 
Ectoine 1 
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Isolation of a proposed peptide 
 
One of the ANG bacterial extracts, Labrenzia sp. ANG18, demonstrated potent antifungal 
activity against all three F. keratoplasticum strains and moderate activity against C. albicans 
(Figure 23). However, the bacterial extract did not exhibit anti-proliferative activity against breast 
cancer cells (MCF-7) (Figure 23). The bacterial extract was fractionated using reverse-phase high 
performance liquid chromatography (C18 HPLC) and tested against F. keratoplasticum FSSC-2g. 
Preliminary results suggest the fraction demonstrates moderate antifungal activity (data not shown, 
confirmatory testing ongoing). Due to the antifungal activity and presence of peak that overlapped 
with lincomycin A via LC-MS (Figure 24), this fraction was selected for further purification 
resulting in the isolation of compound 1 (MB0341AE4), described below. Antifungal testing of 
compound 1 is ongoing to determine if this compound contributes to the potent activity of the 
crude extract.  
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Figure 23. Antifungal and anti-proliferative activity of Labrenzia sp. ANG18 extract 
(MB0341) against F. keratoplasticum, C. albicans, and MCF-7 breast cancer cells. (A) 
Labrenzia sp. ANG 18 demonstrated potent activity against all three strains of F. keratoplasticum 
and (B) exhibited moderate activity against C. albicans. (C) However, the extract exhibited no 
anti-proliferative activity against MCF-7 cells (positive controls: amphotericin B for F. 
keratoplasticum and C. albicans, and doxorubicin for MCF-7). 
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Figure 24. HP-LC chromatogram of Labrenzia sp. ANG18 fraction (MB0341AE) (red) and 
lincomycin A standard (blue).  
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Partial characterization of compound 1  
The 1H NMR spectrum for compound 1 (Figure 25A) indicated the presence of a para-
substituted phenyl group, two methyls, seven methylenes, and four methines, which were 
confirmed using the DEPT135 NMR (Figure 25B). The 13C NMR spectrum (Figure 25C) 
suggested the presence of three carboxyls at δC 170.4, 168.7, and 164.9. The COSY NMR 
correlation between the two methyls at δH 1.12 and 0.96 to the methine at δH 2.51 (Figure 26), and 
the HMBC correlation between the methyl protons and the methine carbon (δC 60.2) confirmed an 
isopropyl substructure (Figure 28).  A hydroxyl group was determined to be at position C-6 of the 
para-substituted phenyl group due to the downfield shift δC 155.6 and HMBC correlations of the 
aromatic protons at δH 6.72 and 7.06 to C-6 (Figure 28).  There were strong HMBC correlations of 
H-7 to C-2 and C-4 confirming an adjacent methylene and HMBC correlations of H-7 to one of 
the carboxyls (C-9) (Figure 28).  
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Figure 25. 1H NMR (A), DEPT135 NMR (B), and 13C NMR (C) spectra of MB0341AE4. 
Spectra were collected at 500 MHz for 1H and 125 MHz for 13C in CD3OD. 
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Conclusions  
 Utilizing comparative metabolomics, antifungal activity, and experimentally-driven 
microbial interactions from egg clutch experiments prioritized secondary metabolites present in 
the active bacterial extracts and either the challenged clutches or control clutches for further 
investigation. The results suggest lincomycin B is present in both the control clutches and 
Labrenzia sp. ANG18. Whole genome sequencing of Labrenzia sp. ANG18 confirmed the 
presence of lincomycin biosynthesis genes, strengthening the evidence that Labrenzia sp. ANG18 
is able to produce lincomycin B.  
Overall, there are 10 mass spectral features of interest. Three features were found in both 
the control clutches and active bacterial extracts and one of those was identified as lincomycin B.  
In addition, there were seven features present in both the challenged clutches and active bacterial 
extracts that have yet to be identified. Future studies will include comparing masses of the 
unknown features to other natural product databases and searching for these features in additional 
ANG and JC bacteria extracts.  
Labrenzia sp. ANG18 was pursued for additional secondary metabolites due to the potent 
activity against F. keratoplasticum and C. albicans. Using a suite of NMR analyses, the structure 
of a proposed peptide has been partially elucidated. Future research will include final structure 
elucidation of the isolated compound and testing in the 96-well antifungal assays. Additionally, 
further investigation of additional bioactive bacterial extracts is ongoing. 
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Experimental 
 
ANG and JC bacterial cultures 
ANG and JC bacterial isolates were cultured in seawater tryptone media (SWT; 5 g/L 
tryptone, 3 g/L yeast extract, 700 mL/L Instant Ocean sea salts, 300 mL/L deionized water) using 
a three-step process optimized for the production of secondary metabolites. Briefly, small-scale 
cultures were prepared in a 24-deep-well plate by inoculating select bacterial colonies into 5 mL 
of media. Then, medium-scale cultures were prepared by transferring 1.5 mL of the small-scale 
cultures into 125 mL baffled flasks with 50 mL media. Lastly, large-scale cultures were prepared 
by transferring 15 mL of medium-scale cultures into 1 L baffled flasks with 500 mL of media. 
Each culture was incubated for 3 days at 28 °C while shaking at 200 rpm. 
 
Extraction of ANG and JC bacterial cultures 
 All solvents used for extraction were ACS grade and purchased from Sigma Aldrich (St. 
Louis, MO, USA).  
ANG and JC large-scale cultures were sonicated to lyse cells.  Diaion HP20 resin (Supelco, 
Bellefonte, PA, USA) was pre-washed with methanol followed by Millipore water (EMD 
Millipore, Billerica, MA, USA) and pre-washed resin (10% w/v) was added to the bacterial cultures 
and allowed to incubate overnight at room temperature while shaking at 125 rpm. The culture and 
resin were transferred to a coarse glass filter and washed with Millipore water (2 x 150 mL) to 
remove media components and aqueous material. Subsequently, the resin was sequentially 
extracted with methanol, dichloromethane, and acetone (2 x 150 mL). The organic portions were 
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combined, concentrated in vacuo, and extracted using ethyl acetate to remove any remaining 
aqueous material.   
 
Antifungal assays  
 The 96-well antifungal assays were performed using the same method described in Chapter 
3. 
  
LC-MS/MS analyses and molecular networking   
Extracts were analyzed via LC-MS/MS using a Synapt G2-Si coupled to an Acquity UPLC 
system with an Acquity UPLC HSS T3 column (2.1 x 150 mm, 1.8 µM) connected to an Acquity 
UPLC HSS T3 VanGuard pre-column (2.1 x 5 mm, 1.8 µM). at a flow rate of 0.45 mL/min. 
Samples were prepared at 1 mg/mL in a 1:1 mixture of methanol/water and linear gradient elution 
was performed at 0.45 mL/min with mobile phases A (water with 0.1% formic acid) and B 
(acetonitrile with 0.1% formic acid) using the following conditions: 0.5 min hold at 95% A (0.1% 
formic acid in water) and 5% B (0.1% formic acid in acetonitrile), 3.5 min ramp to 60% B, 4 min 
ramp to 98% B, 1 min hold at 98% B, 0.2 min ramp back to 5% B and a re-equilibration hold at 
5% B for 1.8 min.  
 The instrument was operated in positive, resolution mode using the following parameters: 
2 kV capillary voltage, 100 °C source temperature, 20V sampling cone, 800 L/h desolvation gas 
flow, and 80V source offset. Data was obtained using an 11 min Fast data dependent acquisition 
(Fast DDA) method with a 0.1 sec MS survey scan ranging from m/z 50-2000, followed by five 
0.1 sec data-dependent MS/MS scans of ions with intensities greater than 1000 as determined 
during the preceding scan event. Survey scans were acquired without collision energy (CE) and 
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MS/MS scans were acquired using a linear two-stage low mass (0-20V) and high mass (10-40V) 
CE linear ramp. Lockspray real-time mass correction was turned on to achieve optimal mass 
accuracy by monitoring m/z 556.2771 and m/z 120.0813 ions from simultaneous infusion of a 400 
pg/µL leucine enkephalin solution (0.1% formic acid in a 50% water, 50% methanol solution) with 
0.1 sec scans, a 10 sec scan interval and 3 average scans per correction. 
Data was converted to mzML format using ProteoWizard package (Chambers, et al. 2012) 
and processed in GNPS: Global Natural Products Social Molecular Networking 
[http://gnps.ucsd.edu, (Wang et al., 2016)]. The network with active extracts, inactive extracts, 
clutches challenged with F. keratoplasticum 2g, and control clutches utilized the same parameters 
with the exception of having a fragment ion tolerance of 0.3 Da. The following active extracts (≤ 
25% growth against at least one Fusarium spp.) were grouped together: Labrenzia sp. ANG18, 
Leisingera sp. ANG-S2, Leisingera sp. ANG15, Ruegeria sp. ANG-R, Ruegeria sp. ANG10, 
Alteromonas sp. JC21, Pseudoalteromonas sp. JC22, and Vibrio sp. JC34. In a separate group, the 
following inactive extracts (>76% growth against all three Fusarium spp.) included: Ruegeria sp. 
ANG17, Leisingera sp. ANG-M1, Leisingera sp. ANG-S, Leisingera sp. ANG-VP, Nautella sp. 
ANG-M5, Leisingera sp. ANG-M7, Leisingera sp. ANG1, Ruegeria sp. ANG6, Leisingera sp. 
ANG-DT, Leisingera sp. ANG-S3, Tateyamaria sp. ANG-S1, and Tenacibaculum sp. JC62. Files 
were imported into Cytoscape 3.5.1 and nodes arranged with the default layout.  
Standards and clutch extracts were analyzed using a Waters Xevo G2-XS QToF mass 
spectrometer coupled to a Waters Acquity UPLC. Separations utilized a Waters Acquity UPLC 
HSS T3 column (2.1 x 50 mm, 1.8 µM, 100Å) connected to an Acquity UPLC HSS T3 VanGuard 
pre-column (2.1 x 150 mm, 1.8 µM, 100Å). Conditions were identical to those described above 
with the exception that MS/MS scans were acquired using a linear two-stage low mass (10-40V) 
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and high mass (40-80V) CE linear ramp. The instrument was operated in positive, sensitivity mode 
using the following parameters: 3 kV capillary voltage, 100 °C source temperature, and 30V 
sampling cone. Lockspray real-time mass correction used a simultaneous infusion of a 200 pg/µL 
leucine enkephalin solution.  
 
96-well anti-proliferative assays with solid tumor cells (Gromek et al., 2016) 
Cell line maintenance 
Breast cancer cells (MCF-7) were obtained from the American Type Culture Collection 
(ATCC, Manassas, VA). MCF-7 cells were cultured in DMEM media (Gibco) supplemented with 
10% FBS and 1 penicillin/streptomycin. The cells were grown in Corning Cell Culture, canted 
neck T75 (Fisher Scientific) in an Autoflow IR water-jacketed CO2 incubator (37 °C, 5% CO2). 
Experiments performed in Celltreat Tissue Culture Treated 96 well flat bottom plates. DMSO was 
used to prepare all drug solutions and the final DMSO concentration was not greater than 1%. 
 
Cell viability assay 
Anti-proliferative activity of Labrenzia. sp. ANG18 extract against MCF-7 cells were 
evaluated using a standard MTS-PMS assay. Briefly, a 96 well plate was seeded at 3,000 cells per 
well. Before the addition of test compounds, plates were incubated at 37 °C with 5% CO2 for 24 
h. Then, 1 µL of test compound was added to the well and then incubated for another 72 h. The 
extract was screened at 100 µg/mL. Positive control for experiments were doxorubicin at 10 µM 
and DMSO was used as the negative control. MTS and PMS reagents were prepared according to 
the protocol below and the two reagents were mixed at a ratio of 20 (MTS):1 (PMS). Then, 20 µL 
of the MTS/PMS solution was added to each well. The plate was incubated for another 3 h and 
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then the absorbance of the wells were measured using a Synergy H1 Hybrid Reader (Biotek) at 
490 nm. All experiments were repeated at least two independent times performed in triplicate. 
 
Preparation of MTS and PMS reagents 
MTS reagent (Promega Celltiter 96) was dissolved in sterile PBS (UConn Cell Culture 
Facility) to make a 2 mg/mL solution. Phenazine methosulfate (PMS) reagent (Sigma) was 
dissolved in sterile PBS to make a 0.92 mg/mL solution. MTS and PMS reagents were stored at -
20 °C until needed. 
 
Isolation and structure elucidation of compound 1 
High performance liquid chromatography (HPLC) and was performed on an Agilent 1260 
HPLC system with a G1311 quaternary pump, G1322 degasser, and a G1315 diode array detector 
using an Eclipse XDB-C18 (4.6 × 150 mm, 5 μm) RP-HPLC column. Labrenzia sp. ANG18 was 
pre-fractionated using an isocratic gradient at 55% acetonitrile (ACN) followed by purification 
using an isocratic gradient at 8% ACN to afford 1.4 mg of pure compound. NMR spectra were 
obtained with a Bruker AVANCE 500 MHz spectrometer using MeOD4 as reference and analysis 
was performed on MestReNova version 12.0. 
 
LC-MS profiles of Labrenzia sp. ANG18 
High performance liquid chromatography (HPLC) and was performed on an Agilent 1260 
HPLC system with a G1311 quaternary pump, G1322 degasser, and a G1315 diode array detector 
coupled to an Agilent ESI single quadrupole mass spectrometer. Gradient elution was used from 
25% acetonitrile in 0.1% formic acid (ACNFA)in H2O in 0.1% formic acid to 100% ACNFA, with 
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a 0.7 mL/min flow rate and a 25 µL injection volume (extract prepared at 1 mg/mL in HPLC grade 
methanol) using an Eclipse XDB-C18 (4.6 × 150 mm, 5 μm) RP-HPLC column. Chemical profiles 
were monitored at three different UV absorbances (209 nm, 254 nm, and 299 nm) as well as 
positive and negative mode total ion chromatograms as measured via mass spectrometry. Agilent 
Chemstation software vB04.02 was used to quantitate area under the curve vial manual integration 
of peaks at UV absorbance 254 nm to determine purity.  
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Figure 26. 1H-1H COSY NMR spectra of MB0341AE4. Spectra was collected in CD3OD. 
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Figure 27. 1H-13C HSQC NMR spectra of MB0341AE4. Spectra was collected in CD3OD.  
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Figure 28. 1H-13C HMBC NMR spectra of MB0341AE4. Spectra was collected in CD3OD. 
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Chapter V. Conclusions and Future Directions 
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Host-microbe symbioses between a eukaryotic host and bacterial symbiont have 
traditionally been studied to gain a better understanding of the ecological relevance or nutritional 
exchange among organisms (Schmidt et al., 2012; Lopanik et al., 2014). However, microbial 
symbionts associated with host organisms are emerging as a promising source for novel drug 
discovery because of the potential for bacterial symbionts to produce biologically active 
compounds (Schmidt et al., 2012; Schmidt et al., 2008). Defensive symbioses have been 
investigated in terrestrial and marine invertebrate host-microbe relationships where the bacterial 
symbiont produces secondary metabolites to either inhibit harmful pathogens or ward off predators 
(Kaltenpoth et al., 2014; Schmidt et al. 2012; Schmidt et al., 2008; Cafaro et al., 2011; Koehler et 
al., 2013; Kroiss et al., 2010; Hildebrand et al. 2004, Haygood and Davidson, 1997; Gil-Turnes et 
al., 1989).  
In marine invertebrates, the host-microbe relationships of sessile organisms (e.g., sponges, 
corals, tunicates) with their associated microorganisms are often studied because sessile organisms 
lack mobility and some of their bacterial symbionts are known to produce compounds useful for 
defense against predators and harmful pathogens (Schmidt et al., 2012; Schmidt et al., 2008). In 
mobile organisms (e.g., shrimp, squid) bacterial symbionts may also produce compounds for 
chemical defense, but have typically been related to protection of eggs or larval stages (Gil-Turnes 
and Fenical, 1992; Gil-Turnes et al., 1989; Fraune et al., 2015; Flórez et al., 2015; Lopanik et al., 
2014). 
A beneficial host-microbe symbiotic relationship that has been well studied is the 
interaction of the Hawaiian bobtail squid, Euprymna scolopes, with the bioluminescent bacterium 
Vibrio fischeri within the squid light organ (Nyholm et al, 2002; Nyholm et al.; 2003; Visick et 
al., 2000; McFall-Ngai, 2014). In addition to the light organ, female E. scolopes have an accessory 
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nidamental gland (ANG) that harbors a diverse bacterial consortium primarily composed of 
Alphaproteobacteria, Gammaproteobacteria, and Verrucomicrobia (Kerwin and Nyholm, 2017; 
Collins et al., 2012). While previous research has determined that the nidamental gland (NG) of 
E. scolopes is responsible for producing the JC that surrounds squid eggs, the function of the ANG 
and associated bacteria has been poorly characterized (Kerwin and Nyholm, 2017; Collins et al., 
2015; Collins et al., 2012). Using the Hawaiian bobtail squid as a model organism, the research 
highlighted in this dissertation has focused on identifying biologically active compounds 
associated with the ANG and JC bacteria to gain a better understanding of the role of the ANG 
and the symbiotic relationship of the bacterial community present in the JC.  
In chapter 2, a bacterium isolated from the jelly coat of squid egg clutches, Leisingera sp. 
JC1, was investigated for antimicrobial compounds due to similar pigmentation and colony 
morphology as a Leisingera sp. Y4I bacterial strain that had been reported to produce an 
antimicrobial compound known as indigoidine (Cude et al., 2012). This study utilized mass 
spectrometry techniques [liquid chromatography mass spectrometry (LC-MS) and direct analysis 
in real time mass spectrometry (DART-MS)], in vitro biological assays, and co-culture 
experiments to explore the functional role and regulation of indigoidine when exposed to the light 
organ bacterial symbiont of E. scolopes, V. fischeri, and additional common marine vibrios. The 
production of indigoidine by Leisingera sp. JC1 was confirmed using LC-MS, and the presence of 
this compound mayb be contributing to the microbial defense of squid eggs.  
To further understand the potential antimicrobial activity of indigoidine the two Leisingera 
sp. JC1 extracts, a normal resin-based extract and an indigoidine-enriched extract, tested in a 96-
well assay. Both chemical extracts were screened at 500 µg/mL against V. fischeri, V. anguillarum, 
and V. parahaemolyticus. Intriguingly, the normal extract demonstrated more potent inhibition of 
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V. fischeri than the indigoidine-enriched extract suggesting that indigoidine may not be solely 
responsible for the biological activity. Further analysis by LC-MS showed that the normal extract 
had only trace quantities of indigoidine present. Neither chemical extract inhibited V. anguillarum 
or V. parahaemolyticus. 
The zone of inhibition assays demonstrated that Leisingera sp. JC1 was able to inhibit V. 
fischeri, V. anguillarum (common marine pathogen), and Photobacterium leiognathi 
(bioluminescent bacterium isolated from Hawaiian seawater). However, there was no inhibition of 
V. parahaemolyticus or V. harveyi. There may have been differential activity demonstrated 
between the ZOI and 96-well assays for V. anguillarum because compounds diffuse differently in 
solid media compared to liquid media, the extracts do not have aqueous soluble compounds, or 
possible changes in the redox state of indigoidine. Furthermore, Leisingera sp. JC1 and other 
associated bacteria within the ANG may produce secondary metabolites to prevent V. fischeri from 
colonizing in the ANG.  
The zone of inhibition assays resulted in a significant difference in pigmentation of 
Leisingera sp. JC1 bacterial colonies in the presence and absence of V. fischeri. In the absence of 
V. fischeri, there was uniform production of indigoidine across the colony whereas in the presence 
of V. fischeri there was localization of indigoidine production to the outer edge of the colony. 
Therefore, DART-MS was used to confirm the localization of indigoidine production to the outer 
edge of the colony in the presence of V. fischeri. The localization of indigoidine to the outer edges 
of the colony may be indicative of use as a chemical defense mechanism to protect against V. 
fischeri and potentially other marine pathogens.  
To investigate the regulation of indigoidine production, Leisingera sp. JC1 was co-cultured 
with V. fischeri, V. anguillarum, and V. parahaemolyticus. When Leisingera sp. JC1 was co-
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cultured with V. fischeri there was upregulation of indigoidine production which complemented 
the ZOI and 96-well antimicrobial assays. Conversely, there was down regulation of indigoidine 
when Leisingera sp. JC1 was co-cultured with V. anguillarum and V. parahaemolyticus. Within 
the Hawaiian bobtail squid, the light organ is anterior to the ANG yet V. fischeri has not been 
detected in the ANG. Thus, one role of Leisingera sp. JC1 and other ANG/JC bacterial isolates 
may prevent the colonization of V. fischeri in the ANG. More broadly, Leisingera sp. JC1 and 
other ANG/JC bacterial isolates may play a role in egg defense by producing antimicrobial 
compounds to protect the physically unprotected egg clutches during their embryonic period.   
In chapter 3, bacteria associated with the ANG demonstrated the ability to protect 
developing embryos from fungal fouling suggesting the symbiotic bacteria has a defensive 
function. In vivo experiments subjecting egg clutches to antibiotics killing bacteria from the 
surface of the eggs and in between the JC layers. Eggs treated with antibiotics developed a thick 
biofilm primarily consisting of a fungal isolate identified as Fusarium keratoplasticum, whereas 
eggs that were not treated with antibiotics did not have biofilm formation. Additional controls 
included the treatment of egg clutches with only antibiotics to ensure the antibiotics were not 
affecting the development and growth of the embryos.  
In a separate experiment, squid eggs were dissected to determine if host factors or the JC 
bacterial community was responsible for the antifungal activity. These eggs were not treated with 
antibiotics so the bacteria remained viable and capable of producing antimicrobial compounds. 
The whole eggs, JC and yolk sac (outer capsule removed), and yolk sac alone were challenged 
with F. keratoplasticum. There were fungal hyphae observed on the intact eggs but embryonic 
development was not affected. After the outer capsule was removed, leaving the JC and its 
bacterial community intact, the results were similar to the whole eggs. However, removal of the 
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outer capsule and JC resulted in fungal formation and prevented embryonic development, 
suggesting the JC and associated bacteria may be responsible for the antifungal activity. The results 
from the antibiotic treated egg clutch and dissection experiment stimulated an interest to 
investigate the ANG and JC bacteria for potent biologically active compounds.  
Bacterial isolates from the ANG and JC were cultured, extracted, and tested in a 96-well 
assay against three phylogenetically related F. keratoplasticum strains. The results suggest that 
over 60% of the ANG and JC bacterial extracts are able to reduce fungal growth. More specifically, 
eight of the 33 extracts demonstrate strong inhibition (0-25% growth) and an additional 9 extracts 
exhibit moderate inhibition (26-50% growth) against at least one F. keratoplasticum strain. There 
were also more extracts that either strongly or moderately inhibit the two environmental F. 
keratoplasticum strains, FSSC-2i and FSSC-2g, in comparison to FSSC-2d, phylogenetically 
related but environmentally unrelated fungus, potentially due to the fact that constant exposure of 
ANG and JC bacteria to F. keratoplasticum results in the production of compounds to prevent 
fungal fouling. The potent antifungal activity of the ANG and JC bacterial extracts suggest this 
may be a promising source for discovery and development of novel antifungal compounds. 
Comparative metabolomics was utilized to compare the chemical profiles of the challenged 
clutch extract and control clutch extract, revealing two clusters of compounds only produced in 
the egg clutches challenged with the fungus. Further investigation of these two clusters resulted in 
putative identification of mycinamicin-like and glycerophosphocholine metabolites. Pure 
standards and related compounds were tested in the 96-well antifungal assay with PC 18:1/0:0 
(analogue of lyso-PAF) demonstrating the most potent activity possibly due to the unsaturation in 
the fatty acid tail resulting in more effective penetration of the fungal cell membrane. In addition, 
authenticated standards of mycinamicin IV and VI exhibited weak antifungal activity against F. 
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keratoplasticum FSSC-2g, although confirmation of their presence in the clutch was not 
conclusive.  
In chapter 4, to further understand the function of the ANG and JC bacteria, comparative 
metabolomics, biological assays, and experimentally driven microbial interactions were integrated 
to identify defensive secondary metabolites. A molecular network was generated using ANG/JC 
bacterial extracts demonstrating potent antifungal activity against at least one Fusarium 
keratoplasticum strain, bacterial extracts inactive against all three Fusarium keratoplasticum 
strains, challenged clutches, and control clutches. The molecular network prioritized seven 
features produced by both the challenged clutches and active bacterial extracts and three features 
produced by both the control clutch extract and active extracts for further analyses. Lincomycin B 
was found to be present in both the control clutches and an active bacterial extract, Labrenzia sp. 
ANG18. Whole genome sequencing confirmed the presence of lincomycin biosynthesis genes, 
strengthening the evidence that Labrenzia sp. ANG18 is able to produce lincomycin B. 
Labrenzia sp. ANG18 was pursued for isolation and identification of additional secondary 
metabolites due to the potent and selective activity of the extract against F. keratoplasticum. Using 
a suite of NMR analyses, a proposed peptide consisting of a tyrosine-valine moiety has been 
partially elucidated. Future research will include final structure elucidation of the isolated 
compound and testing the compound in the antimicrobial assays. In addition, techniques such as 
systematic synthetic modifications or in silico programs can be utilized to explore structure-
activity relationships of the most promising lead compounds, as well as work toward determining 
their mode(s) of action. Additionally, further investigation of other bioactive ANG and JC bacterial 
extracts is ongoing. 
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Within the molecular network there were numerous metabolites that have yet to be 
explored. Most importantly, from 10 mass spectral features of interest there were seven features 
that have yet to be identified from both the challenged clutches and active bacterial extracts. 
Moreover, there are still two features present in both the control clutches and active extracts that 
still need to be characterized. Future studies should include comparing the masses of the seven 
compounds to additional natural product databases to determine if the compound is known.  
Labrenzia sp. ANG18 may not be the only bacteria responsible for the production of 
antifungal metabolites. Due to the promising antifungal activity of several ANG and JC bacterial 
extracts against three phylogenetically related F. keratoplasticum strains and C. albicans, studies 
are ongoing to continue screening ANG/JC bacterial extracts against several human fungal 
pathogens including Candida glabrata (wild type), C. glabrata (fluconazole resistant), and C. 
auris (an emergent and particularly infectious fungal strain). In addition, all ANG and JC bacterial 
extracts will be screened against human bacterial pathogens including but not limited to Bacillus 
subtilis, methicillin-sensitive Staphylococcus aureus, methicillin-resistant S. aureus (MRSA), and 
Pseudomonas aeruginosa.  
 In addition to the antimicrobial activity of the ANG and JC bacterial extracts highlighted 
in this dissertation, six ANG bacterial isolates that all have been identified as Leisingera sp. 
(ANG1, DT, S, M6, S3, S5, M7) demonstrate differential biological activity but share high 
sequence homology (>98% average nucleotide identity). Consequently, an interesting avenue of 
research could be comparing the chemical compounds produced by these six highly homologous 
Leisingera strains, using molecular networking to further understand their differential biological 
activity.  
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Future research should include investigating other classes of bacteria that are less 
represented in the ANG such as Verrucomicrobia and Flavobacteria for antimicrobial secondary 
metabolites as well as continuing to analyze Proteobacteria. Some of the ANG and JC bacteria 
may be difficult to culture under laboratory conditions and/or only produce defensive secondary 
metabolites through interactions with additional members of the JC bacterial community. 
Therefore, synergistic studies testing one or more ANG and JC bacterial extracts in the biological 
assays or co-culturing the ANG and JC bacterial isolates with F. keratoplasticum could lead to 
identification of promising novel compounds.  
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Appendix A: Supplemental Data for Chapter II Bacterial Symbiont, Leisingera sp. JC1, 
Associated with the Hawaiian Bobtail Squid Produces Indigoidine 
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Table A1. Leisingera sp. JC1 indigoidine biosynthesis operon is highly similar to Leisingera 
sp. Y4I. The JC1 biosynthesis operon was compared to additional bacterial strains that produce 
indigoidine. [Dr. Andrea Suria obtained all of the data and prepared this table.] 
 
 
*NA, not applicable, no homolog of the gene present in that organism 
  
Gene Annotation 
% Amino acid 
identity to 
Leisingera sp. 
Y4I operon 
% Amino acid 
identity to 
Vogesella 
indigofera 
operon 
% Amino acid 
identity to 
Streptomyces 
lavendulae 
operon 
% Amino acid 
identity to 
Dickeya 
dadantii 3937 
operon 
igiE Cyanate transport protein, CynX 95 58 NA NA 
igiF 4-oxalocrotonate tautomerase 91 NA
* NA NA 
igiD Peptide synthetase 91 53 50 49 
igiC Arylmalonate decarboxylase 95 56 NA NA 
igiB Hydroxyisobutyrate dehydrogenase 93 51 NA NA 
igiR Transcriptional regulator, TetR 90 42 NA NA 
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Figure A1. Leisingera sp. JC1 biosynthetic gene clusters share high similarity to Leisingera 
sp. Y4I biosynthetic gene clusters. [Dr. Andrea Suria obtained all of the data and prepared this 
figure.]  
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Appendix B: Supplemental Data for Chapter III: Bacteria Associated with the Hawaiian 
Bobtail Squid Protect Eggs from Fungal Fouling 
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Figure B1. Treatment of eggs with an antibiotic cocktail and subsequent development of a 
fungal biofilm significantly reduced hatch of juveniles. Eggs were treated with 25 µg/mL of an 
antibiotic cocktail (t4=3.572, p=0.023). Hatching levels were unaffected when eggs were treated 
with the antibiotic cocktail and maintained in a laminar flow hood (t2=1.289, p=0.326) or under 
low temperatures (15-20 °C, t3=0.738, p=0.514) to prevent fungal growth. The antibiotic cocktail 
included penicillin G, kanamycin, spectinomycin, streptomycin, and gentamicin, each at a 
concentration of 25 µg/mL. Data point shape reflects eggs taken from the same initial clutch.  
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Table B1. Percentages of F. keratoplasticum spp. (FSSC-2i, FSSC-2g, and FSSC-2d) and 
Candida albicans wild type (Ca) fungal growth from the 96-well liquid antifungal assay. 
Al
ph
ap
ro
te
ob
ac
te
ri
a 
ANG/JC Isolate Percent Fungal Growth FSSC-2i FSSC-2g FSSC-2d Ca 
Leisingera sp. ANG1 104.3±5.3 106.8±14.9 116.3±14.5 36.7±5.5 
Leisingera sp. ANG13 42.8±1.1 68.0±1.6 49.4±2.5 141.2±10.2 
Leisingera sp. ANG14 33.1±8.2 42.8±8.7 52.2±2.8 132.9±1.5 
Leisingera sp. ANG15 14.8±14.8 48.4±3.2 81.2±4.8 158.9±6.1 
Leisingera sp. ANG-DT 108.3±8.3 109.3±5.6 134.0±4.3 136.7±1.3 
Leisingera sp. JC1 64.0±9.5 99.6±7.5 94.6±11.1 33.3±9.8 
Leisingera sp. JC11 53.5±5.9 45.9±4.8 56.4±2.5 22.5±3.9 
Leisingera sp. JC57 71.4±6.8 79.5±11.4 76.0±5.3 116.3±8.9 
Leisingera sp. JC61 29.1±2.5 43.6±8.1 64.9±14.5 61.2±18.9 
Leisingera sp. ANG-M1 83.3±3.2 87.4±4.8 97.9±13.3 153.4±3.0 
Leisingera sp. ANG-M4 29.8±3.1 66.3±7.7 58.6±0.6 142.0±15.0 
Leisingera sp. ANG-M6 61.0±6.5 66.8±6.4 67.5±10.7 31.2±7.8 
Leisingera sp. ANG-M7 101.2±8.4 89.7±9.6 121.8±10.9 31.4±7.4 
Leisingera sp. ANG-S 90.7±7.1 84.3±5.6 91.5±6.2 152.0±5.1 
Leisingera sp. ANG-S2 -11.7±9.3 16.8±15.0 29.6±15.4 24.2±7.0 
Leisingera sp. ANG-S3 118.7±11.6 138.5±5.5 122.0±11.7 183.8±0.2 
Leisingera sp. ANG-S5 65.8±13.7 66.4±8.8 53.4±8.0 112.0±2.7 
Leisingera sp. ANG-VP 96.5±5.7 97.2±1.5 88.5±12.1 144.7±9.9 
Nautella sp. ANG-M5 98.8±12.3 106.5±4.1 115.5±1.2 165.1±10.7 
Ruegeria sp. ANG6 104.7±5.4 117.8±10.1 104.9±8.9 137.3±12.2 
Ruegeria sp. ANG10 8.6±13.7 -15.1±29.0 16.6±13.2 122.2±3.6 
Ruegeria sp. ANG17 75.5±0.5 74.6±6.5 89.9±0.1 102.7±1.8 
Ruegeria sp. JC13 62.9±5.6 41.1±12.1 55.3±10.4 146.3±10.2 
Ruegeria sp. ANG-R -150.9±22.7 -230.0±3.7 -109.6±14.7 110.0±10.5 
Ruegeria sp. ANG-S4 118.2±2.6 55.9±3.4 34.1±1.4 168.7±3.3 
Tateyamaria sp. ANG-S1 134.3±8.3 125.1±8.8 134.7±14.7 163.9±0.2 
Labrenzia sp. ANG18 -23.3±13.2 -60.9±18.8 -18.9±13.9 42.4±14.3 
G
am
m
a.
 
Alteromonas sp. JC21 12.7±14.8 13.7±21.2 18.4±8.8 164.3±5.3 
Pseudoalteromonas sp. 
JC22 
-89.6±3.2 55.5±8.0 53.3±14.6 24.7±7.4 
Pseudoalteromonas sp. 
JC28 
42.3±0.5 39.3±8.1 62.6±9.5 19.8±4.2 
Vibrio sp. JC34 7.8±10.8 4.9±11.1 16.4±7.6 116.7±3.7 
Flavo. Muricauda sp. ANG21 36.5±11.7 78.8±5.9 89.0±8.4 24.3±3.0 Tenacibaculum sp. JC62 116.3±0.7 96.0±6.4 123.9±1.4 127.0±6.0 
Controls Amp B (Pos. control) 9.7±4.2 0.3±0.3 2.5±1.4 2.0±0.4 DMSO (Neg. control) 100±0.0 100±0.0 100±0.0 100±0.0 
Percentages are an average of at least 2 biological replicates performed in technical triplicate ± the 
standard error of the mean. Gamma. (Gammaproteobacteria), Flavo. (Flavobacteriia). 
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Experimental 
 
Antibiotic Clutch Experiments 
 Adult female Euprymna scolopes were collected from a protected sandflat in Maunlua 
Bay, Oahu, HI (21°26'3.36" N, 157°47'20.78" W) and were shipped to the University of 
Connecticut to be maintained in aquaria. Egg clutches laid in captivity by these squid were split 
into similarly sized groups and placed in aerated filter-sterilized artificial seawater (FSSW). Clutch 
segments were treated with either an antibiotic cocktail (25 µg/mL each of penicillin G, 
kanamycin, spectinomycin, streptomycin, and gentamicin) or 25 µg/mL chloramphenicol, and 
were monitored over a four-week period with daily water changes and fresh antibiotics. The 
viability of each clutch group was determined once hatching was complete (two days without 
additional juveniles produced) by dividing the number of unhatched eggs by the number of total 
eggs (number of unhatched eggs added to the number of juveniles produced). Health of a subset 
of hatched juveniles was checked by inoculating the water with the light organ symbiont, Vibrio 
fischeri, and determining whether colonization occurred. Percent hatch was compared between 
untreated and antibiotic-treated clutches using a paired two-tailed t-test.  
 
Fungal Isolation and Characterization  
Fusarium keratoplasticum FSSC-2g (12-1807) was isolated from an egg clutch treated 
with chloramphenicol as described above. During culturing experiments with F. keratoplasticum 
FSSC-2g we did not observe growth or germination at temperatures between 15-20 °C on SWT 
media.  
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  F. keratoplasticum FSSC-2i (66667) was isolated from a clutch deposited by a wild female 
while maintained in a tank with natural Hawaiian seawater and Hawaiian sand at Kewalo Marine 
Laboratory, Oahu, HI. The clutch was divided into two groups, one was untreated and the other 
treated with 25 µg/mL of antibiotic cocktail for one week while in an aerated beaker with daily 
water changes. After one week both groups were transferred back to their original tank with 
running seawater for the remainder of embryogenesis. The untreated group had 94% viability, 
while the antibiotic-treated section had 10% clutch viability and developed a biofilm. The outer 
capsule of an egg that did not hatch and a decapsulated egg containing a viable embryo from the 
antibiotic-treated section were both plated onto seawater tryptone (SWT) to ensure sampling of 
diverse fungi.  
Both fungal cultures were further isolated on inhibitory mold agar with 0.05 g/L 
gentamicin. Initial identification of fungal isolates occurred by analysis of morphologic 
characteristics on carnation leaf agar and DNA sequence analysis of the ITS-1 region of  rRNA. 
PCR was performed using two general fungal ITS-1 primers (ITS-5, 5'-
GGAAGTAAAAGTCGTAACAAGG-3'; ITS-2, 5'-GGAAGTAAAAGTCGTAACAAGG-3', 41) 
and GoTaq polymerase (Promega, Madison, WI) with the following profile conditions: initial 
denaturation for 3 min at 95 °C; 30 cycles of denaturation for 30 sec at 95 °C, annealing for 30 sec 
at 62 °C, and elongation for 1 min at 72 °C. PCR products were sequenced in both directions and 
identified as F. keratoplasticum via databases BLASTn analysis at NCBI 
(http://www.ncbi.nlm.nih.gov/BLAST/) and RDP (http://rdp.cme.msu.edu/seqmatch). 
Portions of three loci (TEF1, RPB2, ITS + LSU rDNA) were used to precisely identify the 
three Fusarium strains used in the present study as F. keratoplasticum following a published 
protocol (2). Arabic numerals and lowercase roman letters, respectively, identify species and 
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unique 3-locus haplotypes (Figure S3). Maximum parsimony (MP) and maximum likelihood (ML) 
phylogenetic analyses were conducted, respectively, with PAUP* 4.0b10 (3) and GARLI 2.01 (4).  
MP analyses were conducted using the heuristic search option, the tree bisection–reconnection 
(TBR) branch-swapping algorithm with MULPARS on and 1000 random sequence addition 
replicates.  The CIPRES Science Gateway TeraGrid (https://www.phylo.org/) (5) was used to 
conduct the ML analysis employing the GTR + I + Γ model of molecular evolution.  Clade support 
was assessed by 1000 MP and ML bootstrap pseudoreplicates of the data. 
 
Egg Component Experiments  
A method developed for harvesting conidia of Fusarium oxysporum (6) was modified for 
use with F. keratoplasticum. Fusarium keratoplasticum FSSC-2g was grown on a rotary shaker 
for 3-5 days in SWT at 30 °C. The culture was then strained through sterile gauze and centrifuged 
for 10 min at 3,200 x g. Conidia were then rinsed twice with sterile water and re-pelleted after each 
wash, after which they were resuspended in sterile water. Conidia were quantified using a 
hemocytometer and correlated with OD530 to determine a conversion factor of 3x106 bud 
cells/mL/OD530. Refrigeration for up to one week was found to have no effect on conidial viability. 
 E. scolopes eggs from one clutch were dissected using sterile forceps into their various 
components: intact eggs, eggs lacking outer capsule, and eggs lacking outer capsule and jelly coat 
(n=4 trials, 8-10 eggs/treatment). Dissections were completed at day 5 of embryogenesis, as earlier 
dissection prevented embryo development. These components were challenged with 104/mL of F. 
keratoplasticum conidia over the course of embryogenesis, which is approximately an order of 
magnitude higher than the eggs were likely to encounter naturally. Eggs were maintained in FSSW 
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with water changes and fresh conidia were added every 2-3 days. They were maintained on a 
rocker to provide aeration. 
 
Transmission Electron Microscopy  
A freshly deposited E. scolopes clutch was divided into three groups. One group was 
untreated, one group was treated with 20 µg/mL of the antibiotic chloramphenicol, and one was 
exposed only to 0.13 µl/mL of 95% ethanol, the solvent for chloramphenicol. Each group was 
maintained in aerated FSSW, which was changed daily. By day 21 a thick fungal biofilm had 
formed on the antibiotic-treated eggs. Decapsulated eggs were prepared for TEM following 
established protocols. No fungal spores or hyphae were observed in the ethanol alone-treated eggs. 
 
Antibiotic-treatment Effects on Bacterial Communities 
Antibiotic-treated (chloramphenicol or antibiotic cocktail as described above) clutch 
segments were maintained in a laminar flow hood to prevent infection and were otherwise treated 
as those described above. Throughout the course of experiments five eggs from the same clutch 
(n=3 replicates) were sampled on days 0, 10, and 21; the JC was isolated by dissection. JCs were 
surface sterilized in ethanol, homogenized in filter-sterilized squid Ringer’s solution [FSSR,], then 
plated on SWT to quantify culturable JC bacterial abundance. Differences in bacterial load 
between antibiotic-treated JCs and untreated JCs were analyzed via two-tailed t-tests for each time 
point.  
Biofilms that formed on clutches treated with antibiotics above were homogenized in FSSR 
(n=12) and biofilm bacterial DNA was extracted using the DNeasy Blood and Tissue kit according 
to the manufacturer’s protocol (Qiagen, Valencia, CA). DNA concentration was determined using 
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the Qubit® dsDNA High Sensitivity assay (ThermoFisher Scientific Inc., Waltham, MA) and 
averaged 1.13 ± 0.79 ng/μl. The V4 region of the 16S rRNA gene was sequenced on an Illumina 
MiSeq (Illumina, San Diego, CA, USA) following established protocols. Sequence data were 
analyzed using QIIME (12) and NMDS plots of Bray Curtis beta-diversity analyses that were 
created in R using the VEGAN package as previously described. Sequence data were compared to 
ANG/JC community data previously published under the project ID ENA PRJEB14655, accession 
numbers ERS1498392 to ERS1498398, ERS1496666 to ERS1496676, and ERS1496678 to 
ERS1496722. Biofilm sequences were deposited in the European Nucleotide Archive (ENA) 
under the project ID PRJEB23346.  
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